// Auto-generated by scripts/generate-verified-claims.js on 2025-10-20T11:43:39.968Z
// Do not edit by hand. Re-run the script with updated inputs.

export const MOCK_SIMILAR_PAPERS_LIBRARY = {
  "generatedAt": "2025-10-20T11:43:39.954Z",
  "sourcePdf": {
    "path": "nihms-1786188.pdf",
    "title": "An open science study of ageing in companion dogs",
    "doi": "10.1038/s41586-021-04282-9",
    "pages": 15
  },
  "agent": {
    "maxChars": 9719,
    "promptNotes": ""
  },
  "sourcePaper": {
    "title": "An open science study of ageing in companion dogs",
    "summary": "The Dog Aging Project is a large, open-science longitudinal study of tens of thousands of companion dogs with nested cohorts and biobanking. It aims to characterise ageing phenotypes, develop omics biomarkers, genotype ≥10,000 dogs, and test rapamycin in a randomised, double-masked trial.",
    "keyMethodSignals": [
      "Five nested cohorts with lifetime follow-up across all US states (C1).",
      "Companion-dog model with shared human environments and human-like diseases (C2).",
      "≥10,000 low-pass WGS genomes with imputation for genotype-phenotype mapping (C3).",
      "Annual multi-omic biospecimen kits and QA/QC pipelines for biomarkers (C4).",
      "TRIAD randomised, double-masked, placebo-controlled rapamycin trial (C5)."
    ],
    "searchQueries": [
      "large open-data long-term longitudinal study",
      "companion dogs suitable socially relevant",
      "primary scientific aims include defining",
      "annual multi-omic profiling precision triad",
      "triad trial will test whether"
    ]
  },
  "similarPapers": [
    {
      "identifier": "10.1007/s11357-017-9972-z",
      "title": "A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs",
      "doi": "10.1007/s11357-017-9972-z",
      "url": "https://doi.org/10.1007/s11357-017-9972-z",
      "authors": [
        "Silvan R. Urfer",
        "Tammi L. Kaeberlein",
        "Susan Mailheau",
        "Philip J. Bergman",
        "Kate E. Creevy",
        "Daniel E. L. Promislow",
        "Matt Kaeberlein"
      ],
      "year": 2017,
      "venue": "GeroScience",
      "clusterLabel": "Field deployments",
      "whyRelevant": "Direct interventional template for TRIAD (C5). Echo endpoints and masking align with DAP's planned cardiac outcomes; offers preliminary safety signals where outcomes are anticipatory (Gaps: C5).",
      "overlapHighlights": [
        "Double-masked, placebo-controlled dosing",
        "Echocardiography pre/post with fractional shortening and E/A ratio",
        "Client-owned, middle-aged dogs in home settings"
      ],
      "methodMatrix": {
        "sampleModel": "24 healthy, middle-aged client-owned dogs randomised to rapamycin or placebo.",
        "materialsSetup": "Oral rapamycin capsules and matched placebo; standard clinical consumables.",
        "equipmentSetup": "Veterinary echocardiography; haematology and biochemistry analysers.",
        "procedureSteps": "Ten-week weekly dosing; baseline and end-of-treatment clinical and echocardiographic assessments.",
        "controls": "Parallel placebo arm; double masking of investigators and owners.",
        "outputsMetrics": "Fractional shortening, ejection fraction, E/A ratio, standard clinical laboratory panels.",
        "qualityChecks": "Blinding maintained; safety labs within ranges; adverse events monitored.",
        "outcomeSummary": "Improved systolic and diastolic measures without major side-effects; no lifespan data."
      },
      "gapsOrUncertainties": "Small sample and short duration; no lifespan endpoints; limited external validity."
    },
    {
      "identifier": "10.1073/pnas.2120887119",
      "title": "DNA methylation clocks for dogs and humans",
      "doi": "10.1073/pnas.2120887119",
      "url": "https://doi.org/10.1073/pnas.2120887119",
      "authors": [
        "Steve Horvath",
        "A. T. Lu",
        "A. Haghani",
        "J. A. Zoller",
        "C. Z. Li",
        "A. R. Lim",
        "R. T. Brooke",
        "K. Raj",
        "A. Serres-Armero",
        "D. L. Dreger",
        "A. N. Hogan",
        "J. Plassais",
        "E. A. Ostrander"
      ],
      "year": 2022,
      "venue": "Proceedings of the National Academy of Sciences",
      "clusterLabel": "Insight primers",
      "whyRelevant": "Method blueprint for omics-based ageing biomarkers (C4). Dual-species clocks and time-to-death estimators address DAP's biomarker aims where outcomes are pending (Gaps: C3-C4).",
      "overlapHighlights": [
        "MammalMethylChip40 methylation profiling",
        "Dual human-dog epigenetic clocks",
        "Time-to-death estimator development"
      ],
      "methodMatrix": {
        "sampleModel": "Multi-breed canine blood methylomes with matched human datasets for cross-species modelling.",
        "materialsSetup": "MammalMethylChip40 arrays and standard DNA extraction reagents.",
        "equipmentSetup": "Illumina array scanners and computational pipelines for processing and QC.",
        "procedureSteps": "Train and test epigenetic clocks; cross-species calibration; external validation cohorts.",
        "controls": "Cross-validation folds; tissue and species stratifications; batch adjustments.",
        "outputsMetrics": "Predicted epigenetic age, relative age, time-to-death estimators, model correlations.",
        "qualityChecks": "High correlations reported; sensitivity analyses; robustness tests across cohorts.",
        "outcomeSummary": "Accurate canine clocks suggest feasible biomarkers for ageing and interventions."
      },
      "gapsOrUncertainties": "Limited prospective validation against real lifespan and incident disease."
    },
    {
      "identifier": "10.1371/journal.pone.0269425",
      "title": "Cohort profile: The Golden Retriever Lifetime Study (GRLS)",
      "doi": "10.1371/journal.pone.0269425",
      "url": "https://doi.org/10.1371/journal.pone.0269425",
      "authors": [
        "Julia Labadie",
        "Brenna Swafford",
        "Mara DePena",
        "Kathy Tietje",
        "Rodney Page",
        "Janet Patterson-Kane"
      ],
      "year": 2022,
      "venue": "PLOS ONE",
      "clusterLabel": "Field deployments",
      "whyRelevant": "Large, longitudinal, biospecimen-rich canine cohort mirrors DAP's design (C1) and biobanking (C6). Operationalises annual owner-vet questionnaires and clinical labs similar to DAP Measures and Biospecimens (C4).",
      "overlapHighlights": [
        "Annual owner and veterinarian questionnaires",
        "Standardised annual exams with biospecimen banking",
        "EMR linkage and necropsy confirmation"
      ],
      "methodMatrix": {
        "sampleModel": "3,044 US golden retrievers enrolled young with lifelong follow-up schedules.",
        "materialsSetup": "Blood, serum, urine, faeces, hair, nails; surveys; EMR extraction templates.",
        "equipmentSetup": "Veterinary diagnostics; reference lab testing systems; cold-chain biobanking infrastructure.",
        "procedureSteps": "Annual exams and questionnaires; specimen shipments; malignancy triggers additional reporting.",
        "controls": "Stratified enrolment by region, sex, spay/neuter status; pedigree inclusion rules.",
        "outputsMetrics": "Cancer endpoints, CBC/chemistry panels, thyroid, parasitology, urinalysis, incidence rates.",
        "qualityChecks": "Retention tracking; diagnostic tiering; histology and necropsy verification.",
        "outcomeSummary": "High participation and accumulating cancer endpoints; supports longitudinal biospecimen workflows."
      },
      "gapsOrUncertainties": "Single breed and US-only; owner-report bias still possible."
    },
    {
      "identifier": "10.1371/journal.pone.0325695",
      "title": "Emulating the EPIC trial using VetCompass primary-care data: causal effects of pimobendan in UK dogs with grade IV/VI heart murmurs",
      "doi": "10.1371/journal.pone.0325695",
      "url": "https://doi.org/10.1371/journal.pone.0325695",
      "authors": [
        "K. D. O'Neill",
        "A. Boswood",
        "J. Wilshaw"
      ],
      "year": 2025,
      "venue": "PLOS ONE",
      "clusterLabel": "Field deployments",
      "whyRelevant": "Demonstrates EMR-based phenotyping and target-trial emulation methods relevant to missing-data and analysis-plan gaps (Gaps: C3-C4). Provides non-US external validity parallel to DAP (C1).",
      "overlapHighlights": [
        "De-identified primary-care EMR pipeline",
        "Target-trial emulation with inverse weighting",
        "Manual validation from free-text notes"
      ],
      "methodMatrix": {
        "sampleModel": "928 eligible DMVD dogs among 107,176 under care in UK practices.",
        "materialsSetup": "Primary-care EHR fields, diagnostic codes, medications, bodyweight, mortality entries.",
        "equipmentSetup": "EHR search tools and statistical software for causal inference workflows.",
        "procedureSteps": "Target-trial emulation with inverse weighting and competing-risk models over five years.",
        "controls": "Directed acyclic graph variable selection; standardised differences; practice-group adjustments.",
        "outputsMetrics": "Congestive heart failure incidence, all-cause mortality, restricted mean time lost.",
        "qualityChecks": "Manual chart review, predefined eligibility criteria, multiple sensitivity analyses.",
        "outcomeSummary": "Pimobendan associated with reduced CHF risk; concordant with randomised trial direction."
      },
      "gapsOrUncertainties": "Observational emulation; residual confounding and misclassification remain possible."
    },
    {
      "identifier": "10.1126/science.abk0639",
      "title": "Ancestry-inclusive dog genomics challenges popular breed stereotypes",
      "doi": "10.1126/science.abk0639",
      "url": "https://doi.org/10.1126/science.abk0639",
      "authors": [
        "Kathleen Morrill",
        "Jessica Hekman",
        "Xue Li",
        "Jesse McClure",
        "Brittney Logan"
      ],
      "year": 2022,
      "venue": "Science",
      "clusterLabel": "Sample and model",
      "whyRelevant": "Community-science genetics with owner surveys and low-pass WGS mirrors DAP's genetic aims (C3) and open-data ethos (C6). Also surfaces survey-bias considerations flagged in measurement gaps (C1, C4).",
      "overlapHighlights": [
        "Large owner surveys plus genotyping",
        "Low-pass WGS with imputation and GWAS",
        "Open community enrolment and data sharing"
      ],
      "methodMatrix": {
        "sampleModel": "Diverse purebred and mixed-breed pet dogs with extensive owner-reported phenotypes.",
        "materialsSetup": "Saliva or cheek-swab DNA kits; online survey platforms; sequencing reagents.",
        "equipmentSetup": "Illumina sequencing instruments; variant-calling and quality filtering pipelines.",
        "procedureSteps": "Online enrolment; standardised surveys; low-pass WGS; GWAS controlling relatedness.",
        "controls": "Mixed-model association; ancestry covariates; genotype and sample QC thresholds.",
        "outputsMetrics": "Trait heritabilities, significant loci, breed contribution estimates for behaviour.",
        "qualityChecks": "Replication checks; rater-bias discussion; detailed genotype QC steps.",
        "outcomeSummary": "Behaviour highly polygenic; scalable framework for owner-reported phenotypes and genetics."
      },
      "gapsOrUncertainties": "Survey bias and phenotype noise; limited clinical endpoints."
    }
  ],
  "researchGroups": {
    "maxChars": 7579,
    "truncated": false,
    "text": "Paper: An open science study of ageing in companion dogs\nGroup: Healthy Aging & Longevity (Kaeberlein Lab) (University of Washington)\nWebsite: https://depts.washington.edu/halouconn/\nSummary: DAP co-founder site for longevity therapeutics and companion-dog trials; led the first rapamycin RCT template that TRIAD builds on.\n| Name | Email | Role |\n| --- | --- | --- |\n| Matt Kaeberlein | kaeber@uw.edu | PI |\n| Silvan R. Urfer | check lab website contact form | Senior Lecturer, collaborator on rapamycin studies |\n| General research collaboration | ancillarystudies@dogagingproject.org | DAP ancillary studies intake |\n\nGroup: Dog Aging Project Clinical Hub (Texas A&M VMBS)\nWebsite: https://vetmed.tamu.edu\nSummary: Clinical leadership and coordination for DAP longitudinal measures and TRIAD; primary DAP comms at TAMU.\n| Name | Email | Role |\n| --- | --- | --- |\n| Kate E. Creevy | kcreevy@cvm.tamu.edu | Chief Veterinary Officer, Professor |\n| Jennifer Gauntt | jgauntt@tamu.edu | Director of Communications, DAP media contact |\n| DAP participant support | team@dogagingproject.org | Participant and platform contact |\n\nGroup: Dog Aging Project Biobanking (Cornell Veterinary Biobank)\nWebsite: https://www.vet.cornell.edu/departments/biobank\nSummary: Accredited biobank that processes and stores DAP's annual multi-omic kits and QA/QC pipelines.\n| Name | Email | Role |\n| --- | --- | --- |\n| Programme office | cvb@cornell.edu | Central contact for submissions and access |\n| Marta G. Castelhano | check lab website contact form | Director (DAP biobanking lead) |\n| Staff team | check lab website contact form | Operations and accessioning |\n\nGroup: Promislow Lab (Tufts HNRCA)\nWebsite: https://hnrca.tufts.edu/people/daniel-e-l-promislow\nSummary: Population biology and ageing phenotyping; DAP scientific leadership with continued canine-ageing outputs.\n| Name | Email | Role |\n| --- | --- | --- |\n| Daniel E. L. Promislow | daniel.promislow@tufts.edu | PI |\n| Lab enquiries | check lab website contact form | General contact |\n\nPaper: A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs - GeroScience (2017) (DOI: 10.1007/s11357-017-9972-z)\nGroup: Healthy Aging & Longevity (Kaeberlein Lab) (University of Washington)\nWebsite: https://depts.washington.edu/halouconn/\nSummary: Ran the double-masked, placebo-controlled dosing and echo endpoints that informed DAP's TRIAD cardiac outcomes.\n| Name | Email | Role |\n| --- | --- | --- |\n| Matt Kaeberlein | kaeber@uw.edu | PI |\n| Silvan R. Urfer | check lab website contact form | Senior Lecturer, trial co-author |\n| General research collaboration | ancillarystudies@dogagingproject.org | DAP ancillary studies intake for related work |\n\nPaper: DNA methylation clocks for dogs and humans - PNAS (2022) (DOI: 10.1073/pnas.2120887119)\nGroup: Horvath Lab and Clock Foundation (UCLA and Altos Labs)\nWebsite: https://clockfoundation.org\nSummary: Developers of the MammalMethylChip40 and dual-species dog-human clocks; active post-2020 with new multi-clock frameworks.\n| Name | Email | Role |\n| --- | --- | --- |\n| Steve Horvath | shorvath@mednet.ucla.edu | PI |\n| Ake T. Lu | alu@altoslabs.com | Senior Scientist, chip and clock methods |\n| Amin Haghani | ahaghani@altoslabs.com | Research Scientist, algorithm development |\n\nGroup: Dog Genome Project, Ostrander Lab (NHGRI/NIH)\nWebsite: https://irp.nih.gov/pi/elaine-ostrander\nSummary: Comparative canine genomics group with sustained 2020-2025 outputs and core authors on the PNAS dog clock work.\n| Name | Email | Role |\n| --- | --- | --- |\n| Elaine A. Ostrander | elaine.ostrander@nih.gov | Chief & Distinguished Senior Investigator, PI |\n| Heidi G. Parker | hgparker@nhgri.nih.gov | Associate Investigator |\n| Lab enquiries | dog_genome@mail.nih.gov | Programme contact |\n\nPaper: Cohort profile: The Golden Retriever Lifetime Study (GRLS) - PLOS ONE (2022) (DOI: 10.1371/journal.pone.0269425)\nGroup: Golden Retriever Lifetime Study (Morris Animal Foundation)\nWebsite: https://www.morrisanimalfoundation.org/golden-retriever-lifetime-study\nSummary: Large, biospecimen-rich, annual owner-vet cohort with necropsy confirmation and EMR linkage, mirroring DAP's C1/C4 operational model.\n| Name | Email | Role |\n| --- | --- | --- |\n| GRLS Programme Office | grdogs@caninelifetimehealth.org | Study team contact |\n| GRLS Helpline | Not provided | Phone: 855-447-3647; Phone contact for veterinarians and owners |\n| Study Support | check lab website contact form | Web contact for enrolment and queries |\n\nGroup: Flint Animal Cancer Center (Colorado State University)\nWebsite: https://www.csuanimalcancercenter.org\nSummary: Comparative oncology leadership for GRLS cancer endpoints and necropsy confirmation; active 2024-2025 transition to new director.\n| Name | Email | Role |\n| --- | --- | --- |\n| Centre enquiries | use centre contact form | General contact route |\n| Mercedes Cooper | mercedes.cooper@colostate.edu | FACC Administrator |\n| Research Director's Office | use centre contact form | Research coordination |\n\nPaper: Emulating the EPIC trial using VetCompass primary-care data: causal effects of pimobendan in UK dogs with grade IV/VI heart murmurs - PLOS ONE (2025) (DOI: 10.1371/journal.pone.0325695)\nGroup: VetCompass Programme (Royal Veterinary College, London)\nWebsite: https://www.rvc.ac.uk/vetcompass\nSummary: UK-wide de-identified primary-care EMR pipeline and target-trial emulation methods relevant to DAP's missing-data and causal analysis plans.\n| Name | Email | Role |\n| --- | --- | --- |\n| Programme team | vetcompass@rvc.ac.uk | Central contact for data collaboration |\n| Dan O'Neill | doneill@rvc.ac.uk | Associate Professor, VetCompass co-lead |\n| David Brodbelt | dbrodbelt@rvc.ac.uk | Professor of Evidence-based Vet Med, senior methods lead |\n\nGroup: Cardiology Research Group (Royal Veterinary College)\nWebsite: https://www.rvc.ac.uk/about/our-people/adrian-boswood\nSummary: Led canine cardiology and EPIC/EMR emulation alignment, including echo endpoints and clinical translation.\n| Name | Email | Role |\n| --- | --- | --- |\n| Adrian Boswood | aboswood@rvc.ac.uk | Professor of Veterinary Cardiology |\n| Group enquiries | vetcompass@rvc.ac.uk | Coordination via VetCompass team |\n| Department office | Not provided | Phone: +44 1707 666274; Admin line for Boswood's office |\n\nPaper: Ancestry-inclusive dog genomics challenges popular breed stereotypes - Science (2022) (DOI: 10.1126/science.abk0639)\nGroup: Karlsson Lab, Vertebrate Genomics (UMass Chan & Broad Institute)\nWebsite: https://karlssonlab.org\nSummary: Community-science genetics with owner surveys plus low-pass WGS and imputation, directly mirroring DAP's C3/C6 genetics and open data ethos.\n| Name | Email | Role |\n| --- | --- | --- |\n| Elinor K. Karlsson | elinor.karlsson@umassmed.edu | PI, Director of Vertebrate Genomics at Broad |\n| Lab contact | use lab contact form | General lab enquiries |\n| Darwin's Ark team | team@darwinsark.org | Programme partner and intake for community-science projects |\n\nGroup: Dog Genome Project, Ostrander Lab (NHGRI/NIH)\nWebsite: https://irp.nih.gov/pi/elaine-ostrander\nSummary: Long-running comparative genomics team and co-authors on multiple canine genomics papers that align with DAP's C3/C4 aims; duplicated here due to cross-paper relevance.\n| Name | Email | Role |\n| --- | --- | --- |\n| Elaine A. Ostrander | elaine.ostrander@nih.gov | PI |\n| Heidi G. Parker | hgparker@nhgri.nih.gov | Associate Investigator |\n| Lab enquiries | dog_genome@mail.nih.gov | Programme contact |",
    "structured": {
      "papers": [
        {
          "title": "An open science study of ageing in companion dogs",
          "identifier": null,
          "groups": [
            {
              "name": "Healthy Aging & Longevity (Kaeberlein Lab)",
              "institution": "University of Washington",
              "website": "https://depts.washington.edu/halouconn/",
              "notes": "DAP co-founder site for longevity therapeutics and companion-dog trials; led the first rapamycin RCT template that TRIAD builds on.",
              "researchers": [
                {
                  "name": "Matt Kaeberlein",
                  "email": "kaeber@uw.edu",
                  "role": "PI"
                },
                {
                  "name": "Silvan R. Urfer",
                  "email": "check lab website contact form",
                  "role": "Senior Lecturer, collaborator on rapamycin studies"
                },
                {
                  "name": "General research collaboration",
                  "email": "ancillarystudies@dogagingproject.org",
                  "role": "DAP ancillary studies intake"
                }
              ]
            },
            {
              "name": "Dog Aging Project Clinical Hub",
              "institution": "Texas A&M VMBS",
              "website": "https://vetmed.tamu.edu",
              "notes": "Clinical leadership and coordination for DAP longitudinal measures and TRIAD; primary DAP comms at TAMU.",
              "researchers": [
                {
                  "name": "Kate E. Creevy",
                  "email": "kcreevy@cvm.tamu.edu",
                  "role": "Chief Veterinary Officer, Professor"
                },
                {
                  "name": "Jennifer Gauntt",
                  "email": "jgauntt@tamu.edu",
                  "role": "Director of Communications, DAP media contact"
                },
                {
                  "name": "DAP participant support",
                  "email": "team@dogagingproject.org",
                  "role": "Participant and platform contact"
                }
              ]
            },
            {
              "name": "Dog Aging Project Biobanking",
              "institution": "Cornell Veterinary Biobank",
              "website": "https://www.vet.cornell.edu/departments/biobank",
              "notes": "Accredited biobank that processes and stores DAP's annual multi-omic kits and QA/QC pipelines.",
              "researchers": [
                {
                  "name": "Programme office",
                  "email": "cvb@cornell.edu",
                  "role": "Central contact for submissions and access"
                },
                {
                  "name": "Marta G. Castelhano",
                  "email": "check lab website contact form",
                  "role": "Director (DAP biobanking lead)"
                },
                {
                  "name": "Staff team",
                  "email": "check lab website contact form",
                  "role": "Operations and accessioning"
                }
              ]
            },
            {
              "name": "Promislow Lab",
              "institution": "Tufts HNRCA",
              "website": "https://hnrca.tufts.edu/people/daniel-e-l-promislow",
              "notes": "Population biology and ageing phenotyping; DAP scientific leadership with continued canine-ageing outputs.",
              "researchers": [
                {
                  "name": "Daniel E. L. Promislow",
                  "email": "daniel.promislow@tufts.edu",
                  "role": "PI"
                },
                {
                  "name": "Lab enquiries",
                  "email": "check lab website contact form",
                  "role": "General contact"
                }
              ]
            }
          ]
        },
        {
          "title": "A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs - GeroScience (2017)",
          "identifier": "DOI: 10.1007/s11357-017-9972-z",
          "groups": [
            {
              "name": "Healthy Aging & Longevity (Kaeberlein Lab)",
              "institution": "University of Washington",
              "website": "https://depts.washington.edu/halouconn/",
              "notes": "Ran the double-masked, placebo-controlled dosing and echo endpoints that informed DAP's TRIAD cardiac outcomes.",
              "researchers": [
                {
                  "name": "Matt Kaeberlein",
                  "email": "kaeber@uw.edu",
                  "role": "PI"
                },
                {
                  "name": "Silvan R. Urfer",
                  "email": "check lab website contact form",
                  "role": "Senior Lecturer, trial co-author"
                },
                {
                  "name": "General research collaboration",
                  "email": "ancillarystudies@dogagingproject.org",
                  "role": "DAP ancillary studies intake for related work"
                }
              ]
            }
          ]
        },
        {
          "title": "DNA methylation clocks for dogs and humans - PNAS (2022)",
          "identifier": "DOI: 10.1073/pnas.2120887119",
          "groups": [
            {
              "name": "Horvath Lab and Clock Foundation",
              "institution": "UCLA and Altos Labs",
              "website": "https://clockfoundation.org",
              "notes": "Developers of the MammalMethylChip40 and dual-species dog-human clocks; active post-2020 with new multi-clock frameworks.",
              "researchers": [
                {
                  "name": "Steve Horvath",
                  "email": "shorvath@mednet.ucla.edu",
                  "role": "PI"
                },
                {
                  "name": "Ake T. Lu",
                  "email": "alu@altoslabs.com",
                  "role": "Senior Scientist, chip and clock methods"
                },
                {
                  "name": "Amin Haghani",
                  "email": "ahaghani@altoslabs.com",
                  "role": "Research Scientist, algorithm development"
                }
              ]
            },
            {
              "name": "Dog Genome Project, Ostrander Lab",
              "institution": "NHGRI/NIH",
              "website": "https://irp.nih.gov/pi/elaine-ostrander",
              "notes": "Comparative canine genomics group with sustained 2020-2025 outputs and core authors on the PNAS dog clock work.",
              "researchers": [
                {
                  "name": "Elaine A. Ostrander",
                  "email": "elaine.ostrander@nih.gov",
                  "role": "Chief & Distinguished Senior Investigator, PI"
                },
                {
                  "name": "Heidi G. Parker",
                  "email": "hgparker@nhgri.nih.gov",
                  "role": "Associate Investigator"
                },
                {
                  "name": "Lab enquiries",
                  "email": "dog_genome@mail.nih.gov",
                  "role": "Programme contact"
                }
              ]
            }
          ]
        },
        {
          "title": "Cohort profile: The Golden Retriever Lifetime Study (GRLS) - PLOS ONE (2022)",
          "identifier": "DOI: 10.1371/journal.pone.0269425",
          "groups": [
            {
              "name": "Golden Retriever Lifetime Study",
              "institution": "Morris Animal Foundation",
              "website": "https://www.morrisanimalfoundation.org/golden-retriever-lifetime-study",
              "notes": "Large, biospecimen-rich, annual owner-vet cohort with necropsy confirmation and EMR linkage, mirroring DAP's C1/C4 operational model.",
              "researchers": [
                {
                  "name": "GRLS Programme Office",
                  "email": "grdogs@caninelifetimehealth.org",
                  "role": "Study team contact"
                },
                {
                  "name": "GRLS Helpline",
                  "email": null,
                  "role": "Phone: 855-447-3647; Phone contact for veterinarians and owners"
                },
                {
                  "name": "Study Support",
                  "email": "check lab website contact form",
                  "role": "Web contact for enrolment and queries"
                }
              ]
            },
            {
              "name": "Flint Animal Cancer Center",
              "institution": "Colorado State University",
              "website": "https://www.csuanimalcancercenter.org",
              "notes": "Comparative oncology leadership for GRLS cancer endpoints and necropsy confirmation; active 2024-2025 transition to new director.",
              "researchers": [
                {
                  "name": "Centre enquiries",
                  "email": "use centre contact form",
                  "role": "General contact route"
                },
                {
                  "name": "Mercedes Cooper",
                  "email": "mercedes.cooper@colostate.edu",
                  "role": "FACC Administrator"
                },
                {
                  "name": "Research Director's Office",
                  "email": "use centre contact form",
                  "role": "Research coordination"
                }
              ]
            }
          ]
        },
        {
          "title": "Emulating the EPIC trial using VetCompass primary-care data: causal effects of pimobendan in UK dogs with grade IV/VI heart murmurs - PLOS ONE (2025)",
          "identifier": "DOI: 10.1371/journal.pone.0325695",
          "groups": [
            {
              "name": "VetCompass Programme",
              "institution": "Royal Veterinary College, London",
              "website": "https://www.rvc.ac.uk/vetcompass",
              "notes": "UK-wide de-identified primary-care EMR pipeline and target-trial emulation methods relevant to DAP's missing-data and causal analysis plans.",
              "researchers": [
                {
                  "name": "Programme team",
                  "email": "vetcompass@rvc.ac.uk",
                  "role": "Central contact for data collaboration"
                },
                {
                  "name": "Dan O'Neill",
                  "email": "doneill@rvc.ac.uk",
                  "role": "Associate Professor, VetCompass co-lead"
                },
                {
                  "name": "David Brodbelt",
                  "email": "dbrodbelt@rvc.ac.uk",
                  "role": "Professor of Evidence-based Vet Med, senior methods lead"
                }
              ]
            },
            {
              "name": "Cardiology Research Group",
              "institution": "Royal Veterinary College",
              "website": "https://www.rvc.ac.uk/about/our-people/adrian-boswood",
              "notes": "Led canine cardiology and EPIC/EMR emulation alignment, including echo endpoints and clinical translation.",
              "researchers": [
                {
                  "name": "Adrian Boswood",
                  "email": "aboswood@rvc.ac.uk",
                  "role": "Professor of Veterinary Cardiology"
                },
                {
                  "name": "Group enquiries",
                  "email": "vetcompass@rvc.ac.uk",
                  "role": "Coordination via VetCompass team"
                },
                {
                  "name": "Department office",
                  "email": null,
                  "role": "Phone: +44 1707 666274; Admin line for Boswood's office"
                }
              ]
            }
          ]
        },
        {
          "title": "Ancestry-inclusive dog genomics challenges popular breed stereotypes - Science (2022)",
          "identifier": "DOI: 10.1126/science.abk0639",
          "groups": [
            {
              "name": "Karlsson Lab, Vertebrate Genomics",
              "institution": "UMass Chan & Broad Institute",
              "website": "https://karlssonlab.org",
              "notes": "Community-science genetics with owner surveys plus low-pass WGS and imputation, directly mirroring DAP's C3/C6 genetics and open data ethos.",
              "researchers": [
                {
                  "name": "Elinor K. Karlsson",
                  "email": "elinor.karlsson@umassmed.edu",
                  "role": "PI, Director of Vertebrate Genomics at Broad"
                },
                {
                  "name": "Lab contact",
                  "email": "use lab contact form",
                  "role": "General lab enquiries"
                },
                {
                  "name": "Darwin's Ark team",
                  "email": "team@darwinsark.org",
                  "role": "Programme partner and intake for community-science projects"
                }
              ]
            },
            {
              "name": "Dog Genome Project, Ostrander Lab",
              "institution": "NHGRI/NIH",
              "website": "https://irp.nih.gov/pi/elaine-ostrander",
              "notes": "Long-running comparative genomics team and co-authors on multiple canine genomics papers that align with DAP's C3/C4 aims; duplicated here due to cross-paper relevance.",
              "researchers": [
                {
                  "name": "Elaine A. Ostrander",
                  "email": "elaine.ostrander@nih.gov",
                  "role": "PI"
                },
                {
                  "name": "Heidi G. Parker",
                  "email": "hgparker@nhgri.nih.gov",
                  "role": "Associate Investigator"
                },
                {
                  "name": "Lab enquiries",
                  "email": "dog_genome@mail.nih.gov",
                  "role": "Programme contact"
                }
              ]
            }
          ]
        }
      ],
      "promptNotes": "Each group above maintains a current web presence and recent publications or news since 2020, satisfying the active criterion."
    }
  },
  "claimsAnalysis": {
    "text": "# Executive Summary  - The paper outlines the Dog Aging Project (DAP): \"a long-term longitudinal study of ageing in tens of thousands of companion dogs\" with open-data infrastructure and nested cohorts. Evidence strength: High for study design and infrastructure; Low-Moderate for anticipated outcomes because results are pending. (Abstract; Fig. 1a-c; pp. 2-5)   - Rationale: Companion dogs are proposed as a powerful model for human-relevant ageing due to shared environments, similar diseases, and faster ageing (approximately seven to ten times faster). Evidence strength: Moderate. (pp. 2-3)   - DAP aims: characterise multimorbidity, frailty, inflammageing; genotype ≥10,000 dogs; develop omics-based biomarkers; and run a randomised, double-masked, placebo-controlled rapamycin trial. Evidence strength: Moderate for aims, Low for outcomes. (pp. 4-6; Fig. 3; Table 1)   - Cohorts and scale: >30,000 dogs enrolled; USA-wide; five overlapping cohorts (Pack, Foundation, Precision, TRIAD, Centenarian). Evidence strength: High. (pp. 2-5; Fig. 1a-c)   - Data: comprehensive annual owner surveys, veterinary EMR extraction, biospecimens, low-pass WGS, environmental linkages. Evidence strength: High for plans and early operations. (pp. 4-6; Fig. 3; Table 1)   - Open science: de-identified data via Terra and biospecimens via a Cornell-hosted Biobank; first release planned Q1 2022. Evidence strength: High for commitment. (p. 7)   - Ethics/operations: IACUC approvals; informed consent; advisory boards; strong owner engagement. Evidence strength: High for governance. (pp. 6-7; p. 8)   - Key limitations: largely prospective; US-only; potential selection bias toward regularly vetted dogs; heavy reliance on owner report. (pp. 3-5; Table 1)  ---  # Key Claims and Evidence  **C1. DAP is a large, open-data, long-term longitudinal study of companion-dog ageing with nested cohorts.**   - **Evidence summary:** Programme description with five cohorts: Pack, Foundation, Precision, TRIAD (rapamycin RCT), and Centenarian; >30,000 participants; USA-wide; lifetime follow-up. (Abstract; Fig. 1a-c; pp. 2-5)   - **Key numbers:** >30,000 dogs; one dog per household; all 50 US states; Centenarian = top 0.1% of size-specific age distribution. (pp. 2-5; Fig. 1a-c)   - **Source location:** Abstract; pp. 2-5; Fig. 1a-c.   - **Strength:** **High** (descriptive).  **C2. Companion dogs are a suitable and socially relevant model for ageing research.**   - **Evidence summary:** Dogs vary widely in phenotype and lifespan, share human environments and healthcare, experience human-like age-related diseases, and age ~7-10× faster, enabling feasible longitudinal and interventional studies. (pp. 2-3)   - **Key quote:** \"Companion dogs experience nearly every functional decline and disease of ageing that people do\" (≤30 words). (p. 2)   - **Source location:** pp. 2-3.   - **Strength:** **Moderate** (rationale-based).  **C3. Primary scientific aims include defining normative canine ageing and mapping genetic architecture using ≥10,000 low-pass WGS genomes.**   - **Evidence summary:** Aim (1) multimorbidity, frailty, inflammageing; Aim (2) ≥10,000 dogs genotyped with imputation; on track to 10,000 genomes by end of 2022. (pp. 4-6)   - **Key numbers:** ≥10,000 WGS (low-pass); size-stratified analyses. (pp. 4-6; Fig. 3a)   - **Source location:** pp. 4-6; Fig. 3a.   - **Strength:** **Moderate** for aims; **Low** for outcomes (prospective).  **C4. Annual multi-omic profiling (metabolome, epigenome, microbiome) in Precision and TRIAD will support biomarker development.**   - **Evidence summary:** Biospecimen kits with blood, plasma/serum, urine, hair, faeces; clinicopathology; accelerometry; processing pipelines and QA/QC described. (pp. 4-6; Fig. 3a; Table 1)   - **Key numbers:** Precision n = 1,000; TRIAD n = 350; sample panels include inflammatory cytokines, lipoprotein profile, plasma metabolome, faecal microbiome. (Fig. 3a; Table 1)   - **Source location:** Fig. 3a; Table 1; pp. 4-6.   - **Strength:** **Moderate** for feasibility; **Low** for biomarker validity (pending).  **C5. The TRIAD trial will test whether one year of weekly low-dose rapamycin improves lifespan and healthspan in large-breed, middle-aged dogs.**   - **Evidence summary:** Randomised, double-masked, placebo-controlled clinical trial; endpoints include lifespan, heart and cognitive function, age-related disease incidence; enrolment began 06/2021. (pp. 5-6)   - **Key numbers:** TRIAD n = 350; seven US veterinary teaching hospitals; one-year course, weekly low dose. (pp. 5-6; Fig. 3a; Table 1)   - **Source location:** pp. 5-6; Fig. 3a; Table 1.   - **Strength:** **Low** (no results yet, though design is strong).  **C6. DAP commits to open science through public data releases and a Biobank.**   - **Evidence summary:** De-identified data on Terra; access via data use agreement; subset of biospecimens banked at Cornell and available to qualified researchers; return-of-data requirement. (p. 7)   - **Key numbers:** First public data release scheduled Q1 2022. (p. 7)   - **Source location:** p. 7.   - **Strength:** **High** (policy commitment and infrastructure).  **C7. Robust ethics, governance, and participant engagement underpin study feasibility and retention.**   - **Evidence summary:** IACUC approvals (AUPs 2018-0401 CAM; 2018-0368 CAM); informed consent; advisory boards including animal welfare and paediatric bioethics; newsletter >85,000 recipients; ~20,000 helpdesk enquiries resolved in 2020; private \"Dog Park\" community. (pp. 3-4, 6-8)   - **Key numbers:** Newsletter >85,000; ~20,000 enquiries; seven teaching hospitals. (pp. 3-4, 6)   - **Source location:** pp. 3-4, 6-8.   - **Strength:** **Moderate-High** (operations documented).  ---  # Gaps & Limitations  - **Prospective outcomes pending (C3-C5):** Most claims about biomarkers, genetic architecture, and rapamycin effects are anticipatory; no efficacy data provided. (pp. 5-7)   - **External validity (C1-C2):** Current participation is US-only; one dog per household; may limit generalisability. (p. 3; Fig. 1b)   - **Selection bias (C1):** Sampled cohorts require qualifying veterinary EMRs; authors note possible bias toward regularly vetted dogs. (p. 4)   - **Measurement bias (C1, C4):** Heavy reliance on owner-reported surveys; although reproducibility piloted, detailed metrics not reported. [DETAIL NEEDED]. (pp. 4-5; Table 1)   - **Missing data/analysis plans (C3-C4):** Statistical analysis plans, handling of missingness, multiplicity controls not detailed. [DETAIL NEEDED].   - **Environmental linkage assumptions (C4):** Geocoded secondary measures may misclassify exposures if dogs move or have variable activity ranges. [ASSUMPTION]. (p. 5; Fig. 3b)   - **Centenarian age validation (C1):** Requires continuous medical records from juvenile period; feasibility across all breeds not quantified. [DETAIL NEEDED]. (p. 3)  ---  # Methods Snapshot  - **Design:** Large-scale, community-science longitudinal cohort with nested sampled cohorts and an embedded RCT (TRIAD). (pp. 2-6; Fig. 1-3)   - **Sample:** Dogs of all breeds, ages, sizes, sexes; >30,000 enrolled across all 50 US states; one dog per household. (pp. 2-5; Fig. 1b-c)   - **Measures:** Annual Health and Life Experience Survey; additional surveys (CSLB, End-of-Life, Morphometrics and Mobility, cognitive tasks); veterinary EMR extraction; accelerometry; clinicopathology; omics; environmental indices. (Table 1; pp. 4-6)   - **Biospecimens:** Cheek swab WGS (low-pass) for ≥10,000; Precision and TRIAD annual or semiannual kits for blood, urine, faeces, hair; immediate clinical assays and biobanking. (Fig. 3a; Table 1; pp. 4-6)   - **Data systems/QA:** REDCap on Azure; documented pre/post-analytical QC; reproducible pipelines with QA metrics. (pp. 4-5)   - **Ethics:** Texas A&M IACUC approvals (AUPs 2018-0401 CAM; 2018-0368 CAM); informed consent modelled on human research; advisory boards and DSMB for TRIAD. (pp. 6-8)  ---  # Risk-of-Bias / Quality Checklist  - **Sampling:** Stratified selection for sampled cohorts to ensure diversity; potential bias toward dogs with regular veterinary care acknowledged. ✅ Note. (p. 4)   - **Randomisation:** TRIAD specified as randomised, double-masked, placebo-controlled. ✅ (pp. 5-6)   - **Blinding:** TRIAD double-masked. ✅ (pp. 5-6)   - **Missing data handling:** Not described. ⚠ [DETAIL NEEDED].   - **Multiplicity/control of false positives:** Not described. ⚠ [DETAIL NEEDED].   - **Selective reporting:** Open-data policy and data use agreement may mitigate; pre-registration not specified. ⚠ [DETAIL NEEDED]. (p. 7)  ---  # Open Questions & Next Steps  - Quantify normative ageing trajectories and validate canine frailty/multimorbidity indices against hard outcomes. (pp. 4-6; Table 1)   - Complete ≥10,000 WGS and report genotype-phenotype associations for age-related traits. (pp. 4-6)   - Validate candidate omics biomarkers prospectively against true lifespan and disease incidence. (p. 6; Fig. 3a; Table 1)   - Report TRIAD outcomes on lifespan, cardiac and cognitive endpoints after the one-year course and follow-up. (pp. 5-6)   - Assess representativeness, retention, and survey reproducibility quantitatively; expand beyond US and consider multi-dog households. (pp. 3-4)   - Publish detailed statistical analysis plans, including handling of missingness and multiplicity.  ---  **Note on OCR or ambiguities:** Minor hyphenation/line-break artefacts present; no numerical contradictions detected. Where the paper states timelines (for example, Q1 2022 releases, June 2021 enrolment), exact calendar dates are not provided in the text. [UNCLEAR] for detailed statistical plans and specific QC metrics.",
    "structured": {
      "executiveSummary": [
        "The paper outlines the Dog Aging Project (DAP): \"a long-term longitudinal study of ageing in tens of thousands of companion dogs\" with open-data infrastructure and nested cohorts. Evidence strength: High for study design and infrastructure; Low-Moderate for anticipated outcomes because results are pending. (Abstract; Fig. 1a-c; pp. 2-5)",
        "Rationale: Companion dogs are proposed as a powerful model for human-relevant ageing due to shared environments, similar diseases, and faster ageing (approximately seven to ten times faster). Evidence strength: Moderate. (pp. 2-3)",
        "DAP aims: characterise multimorbidity, frailty, inflammageing; genotype ≥10,000 dogs; develop omics-based biomarkers; and run a randomised, double-masked, placebo-controlled rapamycin trial. Evidence strength: Moderate for aims, Low for outcomes. (pp. 4-6; Fig. 3; Table 1)",
        "Cohorts and scale: >30,000 dogs enrolled; USA-wide; five overlapping cohorts (Pack, Foundation, Precision, TRIAD, Centenarian). Evidence strength: High. (pp. 2-5; Fig. 1a-c)",
        "Data: comprehensive annual owner surveys, veterinary EMR extraction, biospecimens, low-pass WGS, environmental linkages. Evidence strength: High for plans and early operations. (pp. 4-6; Fig. 3; Table 1)",
        "Open science: de-identified data via Terra and biospecimens via a Cornell-hosted Biobank; first release planned Q1 2022. Evidence strength: High for commitment. (p. 7)",
        "Ethics/operations: IACUC approvals; informed consent; advisory boards; strong owner engagement. Evidence strength: High for governance. (pp. 6-7; p. 8)",
        "Key limitations: largely prospective; US-only; potential selection bias toward regularly vetted dogs; heavy reliance on owner report. (pp. 3-5; Table 1)"
      ],
      "claims": [
        {
          "id": "C1",
          "claim": "DAP is a large, open-data, long-term longitudinal study of companion-dog ageing with nested cohorts.",
          "evidenceSummary": "Programme description with five cohorts: Pack, Foundation, Precision, TRIAD (rapamycin RCT), and Centenarian; >30,000 participants; USA-wide; lifetime follow-up.",
          "keyNumbers": [
            ">30,000 dogs",
            "one dog per household",
            "all 50 US states",
            "Centenarian = top 0.1% of size-specific age distribution"
          ],
          "source": "Abstract; pp. 2-5; Fig. 1a-c",
          "strength": "High",
          "assumptions": "Descriptive infrastructure claim; participation currently US-only; lifetime follow-up per design.",
          "evidenceType": "Programme description (observational cohort infrastructure)"
        },
        {
          "id": "C2",
          "claim": "Companion dogs are a suitable and socially relevant model for ageing research.",
          "evidenceSummary": "Dogs vary widely in phenotype and lifespan, share human environments and healthcare, experience human-like age-related diseases, and age ~7-10× faster, enabling feasible longitudinal and interventional studies.",
          "keyNumbers": [
            "age ~7-10× faster"
          ],
          "source": "pp. 2-3",
          "strength": "Moderate",
          "assumptions": "Model suitability argued on biological and environmental parallels; not an outcomes analysis.",
          "evidenceType": "Rationale/position based on comparative observations"
        },
        {
          "id": "C3",
          "claim": "Primary scientific aims include defining normative canine ageing and mapping genetic architecture using ≥10,000 low-pass WGS genomes.",
          "evidenceSummary": "Aim (1) multimorbidity, frailty, inflammageing; Aim (2) ≥10,000 dogs genotyped with imputation; on track to 10,000 genomes by end of 2022.",
          "keyNumbers": [
            "≥10,000 WGS (low-pass)"
          ],
          "source": "pp. 4-6; Fig. 3a",
          "strength": "Moderate",
          "assumptions": "Outcomes pending; schedule stated but results not presented.",
          "evidenceType": "Planned genomic cohort analyses"
        },
        {
          "id": "C4",
          "claim": "Annual multi-omic profiling in Precision and TRIAD will support biomarker development.",
          "evidenceSummary": "Biospecimen kits with blood, plasma/serum, urine, hair, faeces; clinicopathology; accelerometry; processing pipelines and QA/QC described.",
          "keyNumbers": [
            "Precision n = 1,000",
            "TRIAD n = 350"
          ],
          "source": "Fig. 3a; Table 1; pp. 4-6",
          "strength": "Moderate",
          "assumptions": "Feasibility documented; biomarker validity awaits prospective results.",
          "evidenceType": "Planned multi-omic cohort profiling"
        },
        {
          "id": "C5",
          "claim": "The TRIAD trial will test whether one year of weekly low-dose rapamycin improves lifespan and healthspan in large-breed, middle-aged dogs.",
          "evidenceSummary": "Randomised, double-masked, placebo-controlled design; endpoints include lifespan, heart and cognitive function, and age-related disease incidence; enrolment began 06/2021.",
          "keyNumbers": [
            "TRIAD n = 350",
            "seven US veterinary teaching hospitals",
            "one-year course, weekly low dose",
            "enrolment began 06/2021"
          ],
          "source": "pp. 5-6; Fig. 3a; Table 1",
          "strength": "Low",
          "assumptions": "No efficacy data yet; design details only.",
          "evidenceType": "Planned RCT design"
        },
        {
          "id": "C6",
          "claim": "DAP commits to open science through public data releases and a Biobank.",
          "evidenceSummary": "De-identified data available on Terra via data use agreement; subset of biospecimens banked at Cornell and available to qualified researchers with data return requirement.",
          "keyNumbers": [
            "First public data release scheduled Q1 2022"
          ],
          "source": "p. 7",
          "strength": "High",
          "assumptions": "Policy and infrastructure statements; timelines stated.",
          "evidenceType": "Policy/infrastructure commitment"
        },
        {
          "id": "C7",
          "claim": "Robust ethics, governance, and participant engagement underpin study feasibility and retention.",
          "evidenceSummary": "IACUC approvals; informed consent; advisory boards; strong owner engagement via newsletter, helpdesk, and private community.",
          "keyNumbers": [
            "Newsletter >85,000",
            "~20,000 enquiries (2020)",
            "seven teaching hospitals"
          ],
          "source": "pp. 3-4, 6-8",
          "strength": "Moderate",
          "assumptions": "Operational metrics documented; effectiveness not quantified against retention outcomes.",
          "evidenceType": "Operations and governance documentation"
        }
      ],
      "gaps": [
        {
          "category": "data gaps",
          "detail": "Most claims about biomarkers, genetic architecture, and rapamycin effects are anticipatory; no efficacy data provided.",
          "relatedClaimIds": [
            "C3",
            "C4",
            "C5"
          ]
        },
        {
          "category": "external validity",
          "detail": "Current participation is US-only; one dog per household; may limit generalisability.",
          "relatedClaimIds": [
            "C1",
            "C2"
          ]
        },
        {
          "category": "methodological weaknesses",
          "detail": "Sampled cohorts require qualifying veterinary EMRs; authors note possible bias toward regularly vetted dogs.",
          "relatedClaimIds": [
            "C1"
          ]
        },
        {
          "category": "methodological weaknesses",
          "detail": "Heavy reliance on owner-reported surveys; although reproducibility piloted, detailed metrics not reported. [DETAIL NEEDED].",
          "relatedClaimIds": [
            "C1",
            "C4"
          ]
        },
        {
          "category": "methodological weaknesses",
          "detail": "Statistical analysis plans, handling of missingness, multiplicity controls not detailed. [DETAIL NEEDED].",
          "relatedClaimIds": [
            "C3",
            "C4"
          ]
        },
        {
          "category": "unresolved confounders",
          "detail": "Geocoded secondary measures may misclassify exposures if dogs move or have variable activity ranges. [ASSUMPTION].",
          "relatedClaimIds": [
            "C4"
          ]
        },
        {
          "category": "data gaps",
          "detail": "Requires continuous medical records from juvenile period; feasibility across all breeds not quantified. [DETAIL NEEDED].",
          "relatedClaimIds": [
            "C1"
          ]
        }
      ],
      "methodsSnapshot": [
        "Design: Large-scale, community-science longitudinal cohort with nested sampled cohorts and an embedded RCT (TRIAD). (pp. 2-6; Fig. 1-3)",
        "Sample: Dogs of all breeds, ages, sizes, sexes; >30,000 enrolled across all 50 US states; one dog per household. (pp. 2-5; Fig. 1b-c)",
        "Measures: Annual Health and Life Experience Survey; additional surveys (CSLB, End-of-Life, Morphometrics and Mobility, cognitive tasks); veterinary EMR extraction; accelerometry; clinicopathology; omics; environmental indices. (Table 1; pp. 4-6)",
        "Biospecimens: Cheek swab WGS (low-pass) for ≥10,000; Precision and TRIAD annual or semiannual kits for blood, urine, faeces, hair; immediate clinical assays and biobanking. (Fig. 3a; Table 1; pp. 4-6)",
        "Data systems/QA: REDCap on Azure; documented pre/post-analytical QC; reproducible pipelines with QA metrics. (pp. 4-5)",
        "Ethics: Texas A&M IACUC approvals (AUPs 2018-0401 CAM; 2018-0368 CAM); informed consent modelled on human research; advisory boards and DSMB for TRIAD. (pp. 6-8)"
      ],
      "riskChecklist": [
        {
          "item": "Sampling",
          "status": "partial",
          "note": "Stratified selection for diversity; potential bias toward regularly vetted dogs acknowledged. (p. 4)"
        },
        {
          "item": "Randomisation",
          "status": "met",
          "note": "TRIAD randomised, double-masked, placebo-controlled. (pp. 5-6)"
        },
        {
          "item": "Blinding",
          "status": "met",
          "note": "TRIAD double-masked. (pp. 5-6)"
        },
        {
          "item": "Missing data handling",
          "status": "missing",
          "note": "[DETAIL NEEDED]."
        },
        {
          "item": "Multiplicity/control of false positives",
          "status": "missing",
          "note": "[DETAIL NEEDED]."
        },
        {
          "item": "Selective reporting",
          "status": "partial",
          "note": "Open-data policy may mitigate; pre-registration not specified. (p. 7)"
        }
      ],
      "openQuestions": [
        "Quantify normative ageing trajectories and validate canine frailty/multimorbidity indices against hard outcomes. (pp. 4-6; Table 1)",
        "Complete ≥10,000 WGS and report genotype-phenotype associations for age-related traits. (pp. 4-6)",
        "Validate candidate omics biomarkers prospectively against true lifespan and disease incidence. (p. 6; Fig. 3a; Table 1)",
        "Report TRIAD outcomes on lifespan, cardiac and cognitive endpoints after the one-year course and follow-up. (pp. 5-6)",
        "Assess representativeness, retention, and survey reproducibility quantitatively; expand beyond US and consider multi-dog households. (pp. 3-4)",
        "Publish detailed statistical analysis plans, including handling of missingness and multiplicity."
      ],
      "crossPaperComparison": []
    }
  },
  "researcherTheses": {
    "maxChars": 9875,
    "truncated": false,
    "text": "Researcher: Matt Kaeberlein — Kaeberlein Lab, University of Washington\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: An open science study of ageing in companion dogs\n  - Year: 2022\n  - Venue: Nature\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Marta G. Castelhano — Cornell University College of Veterinary Medicine (links to DAP Biobanking at Cornell)\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: An open science study of ageing in companion dogs\n  - Year: 2022\n  - Venue: Nature\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Silvan R. Urfer\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs\n  - Year: 2017\n  - Venue: GeroScience\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Tammi L. Kaeberlein\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs\n  - Year: 2017\n  - Venue: GeroScience\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Susan Mailheau\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs\n  - Year: 2017\n  - Venue: GeroScience\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Philip J. Bergman\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs\n  - Year: 2017\n  - Venue: GeroScience\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Kate E. Creevy — Texas A&M University, VMBS (DAP Clinical Hub)\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs\n  - Year: 2017\n  - Venue: GeroScience\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Daniel E. L. Promislow\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs\n  - Year: 2017\n  - Venue: GeroScience\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Steve Horvath — Horvath/UCLA\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: DNA methylation clocks for dogs and humans\n  - Year: 2022\n  - Venue: PNAS\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: A. T. Lu\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: DNA methylation clocks for dogs and humans\n  - Year: 2022\n  - Venue: PNAS\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: A. Haghani\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: DNA methylation clocks for dogs and humans\n  - Year: 2022\n  - Venue: PNAS\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: J. A. Zoller\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: DNA methylation clocks for dogs and humans\n  - Year: 2022\n  - Venue: PNAS\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: C. Z. Li\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: DNA methylation clocks for dogs and humans\n  - Year: 2022\n  - Venue: PNAS\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: A. R. Lim\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: DNA methylation clocks for dogs and humans\n  - Year: 2022\n  - Venue: PNAS\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: R. T. Brooke\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: DNA methylation clocks for dogs and humans\n  - Year: 2022\n  - Venue: PNAS\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: K. Raj\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: DNA methylation clocks for dogs and humans\n  - Year: 2022\n  - Venue: PNAS\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: A. Serres-Armero — Universitat Pompeu Fabra, Comparative Genomics (Marquès-Bonet group; Dog Genome Project collaborator)\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: DNA methylation clocks for dogs and humans\n  - Year: 2022\n  - Venue: PNAS\n  - URL: Not found\nPhD thesis:\n  - Title: Understanding dog breed copy number differences in the framework of gray wolf copy number variation\n  - Year: 2020\n  - Institution: Universitat Pompeu Fabra\n  - URL: https://www.tesisenred.net/handle/10803/668662\n\nResearcher: D. L. Dreger\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: DNA methylation clocks for dogs and humans\n  - Year: 2022\n  - Venue: PNAS\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: A. N. Hogan\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: DNA methylation clocks for dogs and humans\n  - Year: 2022\n  - Venue: PNAS\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: J. Plassais\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: DNA methylation clocks for dogs and humans\n  - Year: 2022\n  - Venue: PNAS\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: E. A. Ostrander — Dog Genome Project, NHGRI\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: DNA methylation clocks for dogs and humans\n  - Year: 2022\n  - Venue: PNAS\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Julia Labadie\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Cohort profile: The Golden Retriever Lifetime Study (GRLS)\n  - Year: 2022\n  - Venue: PLOS ONE\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Brenna Swafford\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Cohort profile: The Golden Retriever Lifetime Study (GRLS)\n  - Year: 2022\n  - Venue: PLOS ONE\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Mara DePena\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Cohort profile: The Golden Retriever Lifetime Study (GRLS)\n  - Year: 2022\n  - Venue: PLOS ONE\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Kathy Tietje\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Cohort profile: The Golden Retriever Lifetime Study (GRLS)\n  - Year: 2022\n  - Venue: PLOS ONE\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Rodney Page — Colorado State University / Flint Animal Cancer Center\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Cohort profile: The Golden Retriever Lifetime Study (GRLS)\n  - Year: 2022\n  - Venue: PLOS ONE\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Janet Patterson-Kane\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Cohort profile: The Golden Retriever Lifetime Study (GRLS)\n  - Year: 2022\n  - Venue: PLOS ONE\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: K. D. O'Neill — VetCompass Programme, Royal Veterinary College\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Emulating the EPIC trial using VetCompass primary-care data: causal effects of pimobendan in UK dogs with grade IV/VI heart murmurs\n  - Year: 2025\n  - Venue: PLOS ONE\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: A. Boswood\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Emulating the EPIC trial using VetCompass primary-care data: causal effects of pimobendan in UK dogs with grade IV/VI heart murmurs\n  - Year: 2025\n  - Venue: PLOS ONE\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: J. Wilshaw\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Emulating the EPIC trial using VetCompass primary-care data: causal effects of pimobendan in UK dogs with grade IV/VI heart murmurs\n  - Year: 2025\n  - Venue: PLOS ONE\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Kathleen Morrill — Karlsson Lab, UMass Chan & Broad Institute\nEmail: Not provided\nData publicly available: yes\nLatest publication:\n  - Title: Ancestry-inclusive dog genomics challenges popular breed stereotypes\n  - Year: 2022\n  - Venue: Science\n  - URL: Not found\nPhD thesis:\n  - Title: Comparative neurogenetics of dog behavior complements efforts towards psychiatric genomics\n  - Year: 2023\n  - Institution: UMass Chan eScholarship\n  - URL: https://repository.escholarship.umassmed.edu/handle/20.500.14038/52650\n\nResearcher: Jessica Hekman\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Ancestry-inclusive dog genomics challenges popular breed stereotypes\n  - Year: 2022\n  - Venue: Science\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Xue Li\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Ancestry-inclusive dog genomics challenges popular breed stereotypes\n  - Year: 2022\n  - Venue: Science\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Jesse McClure\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Ancestry-inclusive dog genomics challenges popular breed stereotypes\n  - Year: 2022\n  - Venue: Science\n  - URL: Not found\nPhD thesis: Not found\n\nResearcher: Brittney Logan\nEmail: Not provided\nData publicly available: unknown\nLatest publication:\n  - Title: Ancestry-inclusive dog genomics challenges popular breed stereotypes\n  - Year: 2022\n  - Venue: Science\n  - URL: Not found\nPhD thesis: Not found",
    "structured": {
      "researchers": [
        {
          "name": "Matt Kaeberlein",
          "email": null,
          "group": "Kaeberlein Lab, University of Washington",
          "latest_publication": {
            "title": "An open science study of ageing in companion dogs",
            "year": 2022,
            "venue": "Nature",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Marta G. Castelhano",
          "email": null,
          "group": "Cornell University College of Veterinary Medicine (links to DAP Biobanking at Cornell)",
          "latest_publication": {
            "title": "An open science study of ageing in companion dogs",
            "year": 2022,
            "venue": "Nature",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Silvan R. Urfer",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs",
            "year": 2017,
            "venue": "GeroScience",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Tammi L. Kaeberlein",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs",
            "year": 2017,
            "venue": "GeroScience",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Susan Mailheau",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs",
            "year": 2017,
            "venue": "GeroScience",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Philip J. Bergman",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs",
            "year": 2017,
            "venue": "GeroScience",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Kate E. Creevy",
          "email": null,
          "group": "Texas A&M University, VMBS (DAP Clinical Hub)",
          "latest_publication": {
            "title": "A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs",
            "year": 2017,
            "venue": "GeroScience",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Daniel E. L. Promislow",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs",
            "year": 2017,
            "venue": "GeroScience",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Steve Horvath",
          "email": null,
          "group": "Horvath/UCLA",
          "latest_publication": {
            "title": "DNA methylation clocks for dogs and humans",
            "year": 2022,
            "venue": "PNAS",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "A. T. Lu",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "DNA methylation clocks for dogs and humans",
            "year": 2022,
            "venue": "PNAS",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "A. Haghani",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "DNA methylation clocks for dogs and humans",
            "year": 2022,
            "venue": "PNAS",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "J. A. Zoller",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "DNA methylation clocks for dogs and humans",
            "year": 2022,
            "venue": "PNAS",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "C. Z. Li",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "DNA methylation clocks for dogs and humans",
            "year": 2022,
            "venue": "PNAS",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "A. R. Lim",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "DNA methylation clocks for dogs and humans",
            "year": 2022,
            "venue": "PNAS",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "R. T. Brooke",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "DNA methylation clocks for dogs and humans",
            "year": 2022,
            "venue": "PNAS",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "K. Raj",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "DNA methylation clocks for dogs and humans",
            "year": 2022,
            "venue": "PNAS",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "A. Serres-Armero",
          "email": null,
          "group": "Universitat Pompeu Fabra, Comparative Genomics (Marquès-Bonet group; Dog Genome Project collaborator)",
          "latest_publication": {
            "title": "DNA methylation clocks for dogs and humans",
            "year": 2022,
            "venue": "PNAS",
            "url": null
          },
          "phd_thesis": {
            "title": "Understanding dog breed copy number differences in the framework of gray wolf copy number variation",
            "year": 2020,
            "institution": "Universitat Pompeu Fabra",
            "url": "https://www.tesisenred.net/handle/10803/668662"
          },
          "data_publicly_available": "yes"
        },
        {
          "name": "D. L. Dreger",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "DNA methylation clocks for dogs and humans",
            "year": 2022,
            "venue": "PNAS",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "A. N. Hogan",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "DNA methylation clocks for dogs and humans",
            "year": 2022,
            "venue": "PNAS",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "J. Plassais",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "DNA methylation clocks for dogs and humans",
            "year": 2022,
            "venue": "PNAS",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "E. A. Ostrander",
          "email": null,
          "group": "Dog Genome Project, NHGRI",
          "latest_publication": {
            "title": "DNA methylation clocks for dogs and humans",
            "year": 2022,
            "venue": "PNAS",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Julia Labadie",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "Cohort profile: The Golden Retriever Lifetime Study (GRLS)",
            "year": 2022,
            "venue": "PLOS ONE",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Brenna Swafford",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "Cohort profile: The Golden Retriever Lifetime Study (GRLS)",
            "year": 2022,
            "venue": "PLOS ONE",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Mara DePena",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "Cohort profile: The Golden Retriever Lifetime Study (GRLS)",
            "year": 2022,
            "venue": "PLOS ONE",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Kathy Tietje",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "Cohort profile: The Golden Retriever Lifetime Study (GRLS)",
            "year": 2022,
            "venue": "PLOS ONE",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Rodney Page",
          "email": null,
          "group": "Colorado State University / Flint Animal Cancer Center",
          "latest_publication": {
            "title": "Cohort profile: The Golden Retriever Lifetime Study (GRLS)",
            "year": 2022,
            "venue": "PLOS ONE",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Janet Patterson-Kane",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "Cohort profile: The Golden Retriever Lifetime Study (GRLS)",
            "year": 2022,
            "venue": "PLOS ONE",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "K. D. O'Neill",
          "email": null,
          "group": "VetCompass Programme, Royal Veterinary College",
          "latest_publication": {
            "title": "Emulating the EPIC trial using VetCompass primary-care data: causal effects of pimobendan in UK dogs with grade IV/VI heart murmurs",
            "year": 2025,
            "venue": "PLOS ONE",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "A. Boswood",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "Emulating the EPIC trial using VetCompass primary-care data: causal effects of pimobendan in UK dogs with grade IV/VI heart murmurs",
            "year": 2025,
            "venue": "PLOS ONE",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "J. Wilshaw",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "Emulating the EPIC trial using VetCompass primary-care data: causal effects of pimobendan in UK dogs with grade IV/VI heart murmurs",
            "year": 2025,
            "venue": "PLOS ONE",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Kathleen Morrill",
          "email": null,
          "group": "Karlsson Lab, UMass Chan & Broad Institute",
          "latest_publication": {
            "title": "Ancestry-inclusive dog genomics challenges popular breed stereotypes",
            "year": 2022,
            "venue": "Science",
            "url": null
          },
          "phd_thesis": {
            "title": "Comparative neurogenetics of dog behavior complements efforts towards psychiatric genomics",
            "year": 2023,
            "institution": "UMass Chan eScholarship",
            "url": "https://repository.escholarship.umassmed.edu/handle/20.500.14038/52650"
          },
          "data_publicly_available": "yes"
        },
        {
          "name": "Jessica Hekman",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "Ancestry-inclusive dog genomics challenges popular breed stereotypes",
            "year": 2022,
            "venue": "Science",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Xue Li",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "Ancestry-inclusive dog genomics challenges popular breed stereotypes",
            "year": 2022,
            "venue": "Science",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Jesse McClure",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "Ancestry-inclusive dog genomics challenges popular breed stereotypes",
            "year": 2022,
            "venue": "Science",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        },
        {
          "name": "Brittney Logan",
          "email": null,
          "group": null,
          "latest_publication": {
            "title": "Ancestry-inclusive dog genomics challenges popular breed stereotypes",
            "year": 2022,
            "venue": "Science",
            "url": null
          },
          "phd_thesis": null,
          "data_publicly_available": "unknown"
        }
      ],
      "promptNotes": "Structured strictly from the analyst notes. Only researchers explicitly connected to theses in the notes received thesis records (A. Serres-Armero, K. Morrill). All other missing fields are set to null or unknown as required."
    },
    "deepDives": {
      "entries": [
        {
          "generatedAt": "2025-10-20T08:54:25.560Z",
          "paper": {
            "title": "DNA methylation clocks for dogs and humans - PNAS (2022)",
            "identifier": "DOI: 10.1073/pnas.2120887119",
            "year": null
          },
          "group": {
            "name": "Dog Genome Project, Ostrander Lab",
            "institution": "NHGRI/NIH",
            "website": "https://irp.nih.gov/pi/elaine-ostrander"
          },
          "text": "Thesis 1\n  Title: Puissance du modèle canin pour les études d'associations: application à la texture du poil et au sarcome histiocytaire\n  Author: Édouard Cadieu\n  Research group: IGDR Rennes, Équipe Génétique du Chien; co-supervision with Dog Genome Project, NHGRI/NIH\n  PI: Elaine A. Ostrander\n  Thesis URL: Not provided\n  Data URL: Not provided\n  Data access: unknown\n  Data synopsis: Thesis-specific data links not confirmed. Likely references canine GWAS resources from the Rennes-NHGRI collaboration; public repositories aligned to hair texture and histiocytic sarcoma GWAS themes exist but were not verified as directly tied to this thesis.\n  Notes: Co-supervised by Catherine André and Elaine A. Ostrander. Thesis PDF not located during this sweep; data availability statement could not be checked. Candidate repositories identified thematically include Dryad, Figshare, and NHGRI Dog Genome Project releases, but no direct accession IDs confirmed.\n\nSources checked:\n- IGDR Rennes thesis pages and team listings\n- Theses.fr national thesis index\n- NHGRI Dog Genome Project data pages\n- Dryad\n- Figshare\n\nFollow-up items:\n- Retrieve the Cadieu thesis PDF from the Rennes institutional repository or Sudoc and extract any accession numbers in Data Availability, Methods, or Appendices\n- If the PDF is not online, contact the IGDR library or the author\n- Contact Ostrander Lab via [dog_genome@mail.nih.gov](mailto:dog_genome@mail.nih.gov) or the PI to confirm thesis-linked datasets\n- Cross-check NIH OxCam programme records for additional Ostrander-co-supervised theses in the last 10-12 years\n\nPrompt notes:\nEscalation: Thesis PDF not publicly discoverable on Rennes portals and may require Sudoc request or direct library assistance. This thesis predates the preferred 10-12-year window but is the clearest Ostrander-co-supervised thesis aligned to canine GWAS datasets relevant to the PNAS 2022 dog-human methylation clock context.",
          "structured": {
            "theses": [
              {
                "thesis_title": "Puissance du modèle canin pour les études d'associations: application à la texture du poil et au sarcome histiocytaire",
                "author": "Édouard Cadieu",
                "year": null,
                "research_group": "IGDR Rennes, Équipe Génétique du Chien; co-supervision with Dog Genome Project, NHGRI/NIH",
                "principal_investigator": "Elaine A. Ostrander",
                "thesis_url": null,
                "data_url": null,
                "data_synopsis": "Thesis-specific data links not confirmed. Likely references canine GWAS resources from the Rennes-NHGRI collaboration; public repositories aligned to hair texture and histiocytic sarcoma GWAS themes exist but were not verified as directly tied to this thesis.",
                "data_access": "unknown",
                "notes": "Co-supervised by Catherine André and Elaine A. Ostrander. Thesis PDF not located during this sweep; data availability statement could not be checked. Candidate repositories identified thematically include Dryad, Figshare, and NHGRI Dog Genome Project releases, but no direct accession IDs confirmed."
              }
            ],
            "sources_checked": [
              "IGDR Rennes thesis pages and team listings",
              "Theses.fr national thesis index",
              "NHGRI Dog Genome Project data pages",
              "Dryad",
              "Figshare"
            ],
            "follow_up": [
              "Retrieve the Cadieu thesis PDF from the Rennes institutional repository or Sudoc and extract any accession numbers in Data Availability, Methods, or Appendices",
              "If the PDF is not online, contact the IGDR library or the author",
              "Contact Ostrander Lab via [dog_genome@mail.nih.gov](mailto:dog_genome@mail.nih.gov) or the PI to confirm thesis-linked datasets",
              "Cross-check NIH OxCam programme records for additional Ostrander-co-supervised theses in the last 10-12 years"
            ],
            "promptNotes": "Escalation: Thesis PDF not publicly discoverable on Rennes portals and may require Sudoc request or direct library assistance. This thesis predates the preferred 10-12-year window but is the clearest Ostrander-co-supervised thesis aligned to canine GWAS datasets relevant to the PNAS 2022 dog-human methylation clock context."
          }
        },
        {
          "generatedAt": "2025-10-20T09:07:49.958Z",
          "paper": {
            "title": "An open science study of ageing in companion dogs",
            "identifier": null,
            "year": null
          },
          "group": {
            "name": "Dog Aging Project Biobanking",
            "institution": "Cornell Veterinary Biobank",
            "website": "https://www.vet.cornell.edu/departments/biobank"
          },
          "text": "Thesis 1\n  Title: FEMORAL HEAD SECONDARY CENTER OF OSSIFICATION DEVELOPMENT IN A CANINE MODEL OF HIP DYSPLASIA: ONSET, MINERAL DENSITY, AND SHAPE\n  Author: Wendy S. Vanden Berg-Foels\n  Year: 2007\n  Research group: Cornell Veterinary Biobank\n  PI: Marta G. Castelhano\n  Thesis URL: https://ecommons.cornell.edu/entities/dissertationorthesis/38b60d60-2290-48ef-be61-0bb0ac1a3e2b\n  Data URL: Not provided\n  Data access: unknown\n  Data synopsis: No repository or data availability links found on the item page; PDF not reviewed. Likely pre-open-data era with data retained in-lab; no public dataset found after cross-checking common repositories. Dead end reason: no explicit Data Availability Statement surfaced.\n  Notes: Senior lead: Rory J. Todhunter. Alternate forms in records: Marta Castelhano, Rory J Todhunter.\n\nSources checked:\n- Cornell eCommons\n- Cornell Graduate School theses collection\n- Dryad\n- Zenodo\n- Figshare\n- NCBI GEO/SRA\n- OATD\n- General web for advisor-linked theses\n- ProQuest Dissertations & Theses Global\n\nFollow-up items:\n- Open the Vanden Berg-Foels 2007 PDF to verify data availability statements and appendices.\n- Query Cornell Library for advisor metadata not indexed in eCommons to filter theses by Advisor: Todhunter or Castelhano.\n- Email CVB programme office at [cvb@cornell.edu](mailto:cvb@cornell.edu) for a list of CVB-supervised PhD theses intersecting DAP ageing with data releases.\n- Check ProQuest for advisor-filtered records; note potential access limits.",
          "structured": {
            "theses": [
              {
                "thesis_title": "FEMORAL HEAD SECONDARY CENTER OF OSSIFICATION DEVELOPMENT IN A CANINE MODEL OF HIP DYSPLASIA: ONSET, MINERAL DENSITY, AND SHAPE",
                "author": "Wendy S. Vanden Berg-Foels",
                "year": 2007,
                "research_group": "Cornell Veterinary Biobank",
                "principal_investigator": "Marta G. Castelhano",
                "thesis_url": "https://ecommons.cornell.edu/entities/dissertationorthesis/38b60d60-2290-48ef-be61-0bb0ac1a3e2b",
                "data_url": null,
                "data_synopsis": "No repository or data availability links found on the item page; PDF not reviewed. Likely pre-open-data era with data retained in-lab; no public dataset found after cross-checking common repositories. Dead end reason: no explicit Data Availability Statement surfaced.",
                "data_access": "unknown",
                "notes": "Senior lead: Rory J. Todhunter. Alternate forms in records: Marta Castelhano, Rory J Todhunter."
              }
            ],
            "sources_checked": [
              "Cornell eCommons",
              "Cornell Graduate School theses collection",
              "Dryad",
              "Zenodo",
              "Figshare",
              "NCBI GEO/SRA",
              "OATD",
              "General web for advisor-linked theses",
              "ProQuest Dissertations & Theses Global"
            ],
            "follow_up": [
              "Open the Vanden Berg-Foels 2007 PDF to verify data availability statements and appendices.",
              "Query Cornell Library for advisor metadata not indexed in eCommons to filter theses by Advisor: Todhunter or Castelhano.",
              "Email CVB programme office at [cvb@cornell.edu](mailto:cvb@cornell.edu) for a list of CVB-supervised PhD theses intersecting DAP ageing with data releases.",
              "Check ProQuest for advisor-filtered records; note potential access limits."
            ],
            "promptNotes": null
          }
        },
        {
          "generatedAt": "2025-10-20T09:19:08.161Z",
          "paper": {
            "title": "An open science study of ageing in companion dogs",
            "identifier": null,
            "year": null
          },
          "group": {
            "name": "Promislow Lab",
            "institution": "Tufts HNRCA",
            "website": "https://hnrca.tufts.edu/people/daniel-e-l-promislow"
          },
          "text": "Thesis 1\n  Title: The companion dog: a powerful model for understanding somatic mutation, disease and aging\n  Author: Ashley Paynter\n  Year: 2023\n  Research group: Promislow Lab - Tufts HNRCA\n  PI: Daniel E. L. Promislow\n  Thesis URL: https://digital.lib.washington.edu/researchworks/items/61f9aff2-4853-47b0-b56c-d2d2e59f31f9\n  Data URL: Not provided\n  Data access: unknown\n  Data synopsis: No explicit data availability or repository links found in the PDF. Work uses Duplex Sequencing on canine blood samples. No SRA or BioProject accession cited.\n  Notes: No dataset link surfaced from the thesis.\n\nThesis 2\n  Title: Natural genetic and phenotypic variation for aging\n  Author: Kelly Jin\n  Year: 2020\n  Research group: Promislow Lab - Tufts HNRCA\n  PI: Daniel E. L. Promislow\n  Thesis URL: https://digital.lib.washington.edu/researchworks/items/096eda70-304f-4684-8065-e3f99f1b7943\n  Data URL: Not provided\n  Data access: unknown\n  Data synopsis: Repository robots blocked direct PDF fetch. No dataset links on the item page. Related public code repository for canine epigenetic clock analyses: [https://github.com/kleejin/canine_epigenetic_clock](https://github.com/kleejin/canine_epigenetic_clock). The repository hosts analysis code rather than raw data.\n  Notes: Includes chapters on dogs as an ageing model and canine epigenomic profiles.\n\nSources checked:\n- University of Washington ResearchWorks ETD\n- UGA Open Scholar ETD\n- NCBI SRA and Run Selector\n- GitHub (author and lab-linked repos)\n- Dog Aging Project publications and AUP pages\n\nFollow-up items:\n- Query NCBI SRA for Duplex Sequencing canine datasets by author names Ashley Paynter and Daniel E. L. Promislow and look for a PRJNA accession.\n- Request full-text PDF for Kelly Jin's thesis via UW access or interlibrary loan to scan for embedded dataset links.\n- Ask Promislow Lab whether thesis-linked data were deposited under DAP's controlled-access Terra repository and whether public mirrors exist.\n- Check if subsequent peer-reviewed articles from these theses include formal data deposits in GEO, SRA, Dryad or Zenodo and back-link to the dissertation chapters.\n- UGA Open Scholar served 403 for the direct dissertation PDF and may require on-campus or mediated access.",
          "structured": {
            "theses": [
              {
                "thesis_title": "The companion dog: a powerful model for understanding somatic mutation, disease and aging",
                "author": "Ashley Paynter",
                "year": 2023,
                "research_group": "Promislow Lab - Tufts HNRCA",
                "principal_investigator": "Daniel E. L. Promislow",
                "thesis_url": "https://digital.lib.washington.edu/researchworks/items/61f9aff2-4853-47b0-b56c-d2d2e59f31f9",
                "data_url": null,
                "data_synopsis": "No explicit data availability or repository links found in the PDF. Work uses Duplex Sequencing on canine blood samples. No SRA or BioProject accession cited.",
                "data_access": "unknown",
                "notes": "No dataset link surfaced from the thesis."
              },
              {
                "thesis_title": "Natural genetic and phenotypic variation for aging",
                "author": "Kelly Jin",
                "year": 2020,
                "research_group": "Promislow Lab - Tufts HNRCA",
                "principal_investigator": "Daniel E. L. Promislow",
                "thesis_url": "https://digital.lib.washington.edu/researchworks/items/096eda70-304f-4684-8065-e3f99f1b7943",
                "data_url": null,
                "data_synopsis": "Repository robots blocked direct PDF fetch. No dataset links on the item page. Related public code repository for canine epigenetic clock analyses: [https://github.com/kleejin/canine_epigenetic_clock](https://github.com/kleejin/canine_epigenetic_clock). The repository hosts analysis code rather than raw data.",
                "data_access": "unknown",
                "notes": "Includes chapters on dogs as an ageing model and canine epigenomic profiles."
              }
            ],
            "sources_checked": [
              "University of Washington ResearchWorks ETD",
              "UGA Open Scholar ETD",
              "NCBI SRA and Run Selector",
              "GitHub (author and lab-linked repos)",
              "Dog Aging Project publications and AUP pages"
            ],
            "follow_up": [
              "Query NCBI SRA for Duplex Sequencing canine datasets by author names Ashley Paynter and Daniel E. L. Promislow and look for a PRJNA accession.",
              "Request full-text PDF for Kelly Jin's thesis via UW access or interlibrary loan to scan for embedded dataset links.",
              "Ask Promislow Lab whether thesis-linked data were deposited under DAP's controlled-access Terra repository and whether public mirrors exist.",
              "Check if subsequent peer-reviewed articles from these theses include formal data deposits in GEO, SRA, Dryad or Zenodo and back-link to the dissertation chapters.",
              "UGA Open Scholar served 403 for the direct dissertation PDF and may require on-campus or mediated access."
            ],
            "promptNotes": null
          }
        },
        {
          "generatedAt": "2025-10-20T10:20:47.840Z",
          "paper": {
            "title": "An open science study of ageing in companion dogs",
            "identifier": null,
            "year": null
          },
          "group": {
            "name": "Healthy Aging & Longevity (Kaeberlein Lab)",
            "institution": "University of Washington",
            "website": "https://depts.washington.edu/halouconn/"
          },
          "text": "Thesis 1\n  Title: An Automated System For High-Throughput Longevity and Healthspan Discovery in Caenorhabditis elegans\n  Author: Benjamin Blue\n  Research group: Healthy Aging & Longevity (Kaeberlein Lab)\n  PI: Matt R. Kaeberlein\n  Thesis URL: https://digital.lib.washington.edu/bitstreams/ceaeea1a-badf-4351-8873-529182f03a72/download\n  Data URL: https://github.com/JasonNPitt/wormbot\n  Data access: public\n  Data synopsis: Open-source code repositories for WormBot and Worm-YOLO pipelines used to generate and analyse high-throughput ageing experiments. Additional link: [https://github.com/paolobif/Worm-Yolo](https://github.com/paolobif/Worm-Yolo)\n  Notes: Thesis cites GitHub repositories as canonical for automation and computer-vision pipelines used to generate and analyse high-throughput ageing experiments; check repo READMEs for licence and usage.\n\nThesis 2\n  Title: Targeting mTOR to Reverse Age-Associated Periodontal Disease\n  Author: Jonathan Y. An\n  Research group: Healthy Aging & Longevity (Kaeberlein Lab)\n  PI: Matt R. Kaeberlein\n  Thesis URL: https://digital.lib.washington.edu/researchworks/bitstreams/af096ff1-85eb-4d4f-8f62-32c59ea19e60/download\n  Data URL: Not provided\n  Data access: unknown\n  Data synopsis: No explicit data availability statement or repository links found. Chapters reference published work on rapamycin and oral microbiome; data may be in associated journal supplements rather than an archived dataset.\n  Notes: PDF lacks a data availability section and contains no repository URLs.\n\nThesis 3\n  Title: Investigation into the effects and mechanisms of rapamycin treatment in two mouse models of Complex I-deficient neurological pathology\n  Author: Melana E. Yanos\n  Research group: Healthy Aging & Longevity (Kaeberlein Lab)\n  PI: Matt R. Kaeberlein\n  Thesis URL: https://digital.lib.washington.edu/bitstreams/8f58ad7b-7968-4941-9d28-0c97f8b90a96/download\n  Data URL: Not provided\n  Data access: unknown\n  Data synopsis: No data availability or repository links found.\n  Notes: Document likely predates common ETD data-sharing norms and contains no GitHub, Zenodo, Dryad, or similar URLs.\n\nThesis 4\n  Title: Analysis of lifespan-extending compounds using growth kinetics and replicative lifespan in Saccharomyces cerevisiae\n  Author: Michael G. Kiflezghi\n  Research group: Healthy Aging & Longevity (Kaeberlein Lab)\n  PI: Matt R. Kaeberlein\n  Thesis URL: https://digital.lib.washington.edu/bitstreams/abc84655-65b0-4309-af2e-843ad974d446/download\n  Data URL: Not provided\n  Data access: unknown\n  Data synopsis: No explicit data availability or repository links identified from the item record and accessible PDF.\n  Notes: ETD listing and accessible PDF do not show a data availability section or URLs.\n\nSources checked:\n- UW ResearchWorks ETD repository\n- Kaeberlein Lab / HALO people pages for supervisor confirmation\n- GitHub repositories linked from the Blue thesis PDF\n\nFollow-up items:\n- Verify and snapshot the GitHub repositories for WormBot and Worm-YOLO and check licences to confirm reuse terms.\n- Re-check UW ETDs where Kaeberlein is chair for appendices or supplemental ZIPs not visible in the PDFs.\n- Search associated journal publications for dataset DOIs referenced in thesis chapters.\n- Expand beyond UW to national portals for Kaeberlein-supervised theses: ProQuest ETD Global, Zenodo, Dryad, Figshare, OSF, NCBI GEO/SRA.\n- For canine-specific datasets tied to Dog Aging Project but not Kaeberlein-supervised theses, review UW ETDs using DAP cohorts (wildfire smoke methylation, PFAS, cognitive function) for collaboration-level datasets.\n- Legacy HALO URL is inactive; rely on active HALO and DLMP sites. Where UW theses are restricted or lack data statements, consider contacting [ancillarystudies@dogagingproject.org](mailto:ancillarystudies@dogagingproject.org).\n\nPrompt notes:\nUse canonical spellings in advisor/supervisor searches: Matt R. Kaeberlein; Silvan R. Urfer. Bias towards the last 10-12 years. Confirm public accessibility and licences for any linked datasets.",
          "structured": {
            "theses": [
              {
                "thesis_title": "An Automated System For High-Throughput Longevity and Healthspan Discovery in Caenorhabditis elegans",
                "author": "Benjamin Blue",
                "year": null,
                "research_group": "Healthy Aging & Longevity (Kaeberlein Lab)",
                "principal_investigator": "Matt R. Kaeberlein",
                "thesis_url": "https://digital.lib.washington.edu/bitstreams/ceaeea1a-badf-4351-8873-529182f03a72/download",
                "data_url": "https://github.com/JasonNPitt/wormbot",
                "data_synopsis": "Open-source code repositories for WormBot and Worm-YOLO pipelines used to generate and analyse high-throughput ageing experiments. Additional link: [https://github.com/paolobif/Worm-Yolo](https://github.com/paolobif/Worm-Yolo)",
                "data_access": "public",
                "notes": "Thesis cites GitHub repositories as canonical for automation and computer-vision pipelines used to generate and analyse high-throughput ageing experiments; check repo READMEs for licence and usage."
              },
              {
                "thesis_title": "Targeting mTOR to Reverse Age-Associated Periodontal Disease",
                "author": "Jonathan Y. An",
                "year": null,
                "research_group": "Healthy Aging & Longevity (Kaeberlein Lab)",
                "principal_investigator": "Matt R. Kaeberlein",
                "thesis_url": "https://digital.lib.washington.edu/researchworks/bitstreams/af096ff1-85eb-4d4f-8f62-32c59ea19e60/download",
                "data_url": null,
                "data_synopsis": "No explicit data availability statement or repository links found. Chapters reference published work on rapamycin and oral microbiome; data may be in associated journal supplements rather than an archived dataset.",
                "data_access": "unknown",
                "notes": "PDF lacks a data availability section and contains no repository URLs."
              },
              {
                "thesis_title": "Investigation into the effects and mechanisms of rapamycin treatment in two mouse models of Complex I-deficient neurological pathology",
                "author": "Melana E. Yanos",
                "year": null,
                "research_group": "Healthy Aging & Longevity (Kaeberlein Lab)",
                "principal_investigator": "Matt R. Kaeberlein",
                "thesis_url": "https://digital.lib.washington.edu/bitstreams/8f58ad7b-7968-4941-9d28-0c97f8b90a96/download",
                "data_url": null,
                "data_synopsis": "No data availability or repository links found.",
                "data_access": "unknown",
                "notes": "Document likely predates common ETD data-sharing norms and contains no GitHub, Zenodo, Dryad, or similar URLs."
              },
              {
                "thesis_title": "Analysis of lifespan-extending compounds using growth kinetics and replicative lifespan in Saccharomyces cerevisiae",
                "author": "Michael G. Kiflezghi",
                "year": null,
                "research_group": "Healthy Aging & Longevity (Kaeberlein Lab)",
                "principal_investigator": "Matt R. Kaeberlein",
                "thesis_url": "https://digital.lib.washington.edu/bitstreams/abc84655-65b0-4309-af2e-843ad974d446/download",
                "data_url": null,
                "data_synopsis": "No explicit data availability or repository links identified from the item record and accessible PDF.",
                "data_access": "unknown",
                "notes": "ETD listing and accessible PDF do not show a data availability section or URLs."
              }
            ],
            "sources_checked": [
              "UW ResearchWorks ETD repository",
              "Kaeberlein Lab / HALO people pages for supervisor confirmation",
              "GitHub repositories linked from the Blue thesis PDF"
            ],
            "follow_up": [
              "Verify and snapshot the GitHub repositories for WormBot and Worm-YOLO and check licences to confirm reuse terms.",
              "Re-check UW ETDs where Kaeberlein is chair for appendices or supplemental ZIPs not visible in the PDFs.",
              "Search associated journal publications for dataset DOIs referenced in thesis chapters.",
              "Expand beyond UW to national portals for Kaeberlein-supervised theses: ProQuest ETD Global, Zenodo, Dryad, Figshare, OSF, NCBI GEO/SRA.",
              "For canine-specific datasets tied to Dog Aging Project but not Kaeberlein-supervised theses, review UW ETDs using DAP cohorts (wildfire smoke methylation, PFAS, cognitive function) for collaboration-level datasets.",
              "Legacy HALO URL is inactive; rely on active HALO and DLMP sites. Where UW theses are restricted or lack data statements, consider contacting [ancillarystudies@dogagingproject.org](mailto:ancillarystudies@dogagingproject.org)."
            ],
            "promptNotes": "Use canonical spellings in advisor/supervisor searches: Matt R. Kaeberlein; Silvan R. Urfer. Bias towards the last 10-12 years. Confirm public accessibility and licences for any linked datasets."
          }
        }
      ]
    }
  },
  "patents": {
    "text": "Patent: US11501851B2\nTitle: Methods and systems for determining ancestral relatedness\nAssignee: Embark Veterinary, Inc.\nFiling Date: 2022-01-06\nGrant Date: 2022-11-15\nAbstract: Algorithms segment dog genomes into haplotypes, detect identical-by-descent (IBD) intervals, and compute weighted scores to estimate degrees of relatedness among canids.\nOverlaps with paper claims: C3\nTechnical overlap: The claims recite receiving phased haplotype data, matching IBD segments across predefined genomic bins, and aggregating weighted scores to infer pairwise relatedness. DAP's ≥10,000 low-pass WGS effort requires kinship and population-structure control for GWAS; the patented IBD segmentation and scoring procedures map directly to building relatedness matrices and detecting cryptic relationships within the cohort. This enables accurate association testing and pedigree deconvolution exactly as contemplated in the paper's genetic architecture aims.\n\nPatent: US7729863B2\nTitle: Methods and materials for canine breed identification\nAssignee: Fred Hutchinson Cancer Research Center\nFiling Date: 2004-08-30\nGrant Date: 2010-06-08\nAbstract: Panels of informative canine genetic markers and statistical classification methods to infer breed composition and relatedness of individual dogs.\nOverlaps with paper claims: C3\nTechnical overlap: Independent claims cover selecting breed-informative SNPs or markers and classifying unknown dogs by comparing genotype profiles with breed reference panels. DAP's genomic analyses require robust breed assignment and stratification control to mitigate confounding in large-scale GWAS; the claimed marker selection and classifier mapping mirror the paper's approach to infer ancestry and adjust models accordingly. This enables proper population structure adjustment that is essential for the paper's planned genetic architecture studies.\n\nPatent: GB2626276A\nTitle: Systems and methods for a pet relative finder\nAssignee: Mars, Incorporated\nFiling Date: 2022-10-26\nGrant Date: Not provided\nAbstract: Computer-implemented methods for predicting familial relationships in companion animals using DNA segment matching and IBD-based metrics.\nOverlaps with paper claims: C3\nTechnical overlap: Claims 1-8 describe receiving pet genomic data, identifying local DNA fragment patterns with shared segments, and computing IBD statistics to infer kinship. DAP's nationwide cohort needs scalable relatedness detection to build relationship graphs and adjust association models; the claimed IBD matching and kinship inference steps are the same computations used to generate the cohort's relatedness matrices. This directly supports the paper's strategy to map canine genetic architecture while controlling for family structure.\n\nPatent: US20220119864A1\nTitle: Canid microbiome monitoring tools\nAssignee: Mars, Incorporated\nFiling Date: Not provided\nGrant Date: Not provided\nAbstract: Methods, compositions, and systems for longitudinal profiling of canid gut microbiomes, including assay panels, reference datasets, and analytics to monitor health status.\nOverlaps with paper claims: C4\nTechnical overlap: The claims disclose serial faecal sampling, microbiome sequencing, and comparative analytics against a reference to detect deviations over time. DAP's Precision/TRIAD cohorts plan annual faecal collections with QA/QC and multi-omic profiling to derive biomarkers; the claimed longitudinal microbiome workflows map to the paper's biomarker development pipeline and temporal deviation detection. This enables monitoring of microbiome-based ageing and disease signatures as described in the study.\n\nPatent: US9615547B2\nTitle: Pet animal collar for health and vital signs monitoring, alert and diagnosis\nAssignee: PetPace Ltd.\nFiling Date: Not provided\nGrant Date: Not provided\nAbstract: A wearable collar integrating accelerometry with temperature, pulse, and respiration sensing, coupled to analytics that derive activity, posture, and health alerts.\nOverlaps with paper claims: C4\nTechnical overlap: Claims cover collecting accelerometer data and physiological signals from a pet, computing activity, rest, posture, and anomaly metrics, and generating alerts. DAP specifies accelerometry and clinicopathology in its annual profiling; the claimed device and algorithms produce the continuous activity and rest features used for frailty and healthspan biomarker development. This provides instrumentation and derived measures directly aligned with the paper's multi-omic phenotyping.\n\nPatent: WO2021124264A1\nTitle: Veterinary formulations comprising rapamycin and methods of using the same for treating animal diseases\nAssignee: TriviumVet DAC\nFiling Date: Not provided\nGrant Date: Not provided\nAbstract: Oral veterinary dosage forms of rapamycin or rapalogs and their use to treat conditions in companion animals, including cardiac dysfunction, cancer, inflammation, and ageing effects.\nOverlaps with paper claims: C5\nTechnical overlap: Independent claims recite canine-applicable oral formulations and dosing ranges for rapamycin to modulate disease processes relevant to ageing. TRIAD tests weekly low-dose rapamycin in middle-aged, large-breed dogs for lifespan and healthspan endpoints; the claimed compositions and veterinary dosing encompass the same active agent, species, and ageing-linked indications operationalised by the trial. This provides coverage over the interventional agent and practical delivery that the paper's RCT implements.\n\nPatent: US20220401421A1\nTitle: Veterinary formulations comprising rapamycin and methods of using the same for treating animal diseases\nAssignee: TriviumVet DAC\nFiling Date: Not provided\nGrant Date: Not provided\nAbstract: US family member describing canine-suitable rapamycin formulations and veterinary dosing methods for treating companion-animal diseases and ageing-associated conditions.\nOverlaps with paper claims: C5\nTechnical overlap: Claims disclose oral dosage forms and dosing regimens for rapamycin in dogs and cats for conditions tied to ageing physiology. The TRIAD protocol's weekly low-dose rapamycin administration in dogs falls within the claimed veterinary use and dosage scope, linking the agent, species, and targeted healthspan outcomes. Thus, the patent family covers the therapeutic composition and use central to the paper's interventional study.\n\nPatent: WO2022272120A1\nTitle: Epigenetic clocks\nAssignee: Not provided\nFiling Date: Not provided\nGrant Date: Not provided\nAbstract: DNA methylation-based models using conserved CpG sites to estimate chronological or biological age across mammals, with embodiments for dogs and cross-species clocks and use in monitoring interventions.\nOverlaps with paper claims: C4, C5\nTechnical overlap: Independent disclosures specify CpG marker sets and regression frameworks for canine and dual-species epigenetic clocks and methods to quantify age shift pre- and post-treatment. DAP's annual multi-omic profiling seeks ageing biomarkers and TRIAD requires surrogate measures of biological-age response to rapamycin; the claimed methylation clocks map directly to these measurement needs. This enables objective, model-based tracking of intervention effects and normative ageing trajectories as outlined in the paper.",
    "structured": {
      "patents": [
        {
          "patentNumber": "US11501851B2",
          "title": "Methods and systems for determining ancestral relatedness",
          "assignee": "Embark Veterinary, Inc.",
          "filingDate": "2022-01-06",
          "grantDate": "2022-11-15",
          "abstract": "Algorithms segment dog genomes into haplotypes, detect identical-by-descent (IBD) intervals, and compute weighted scores to estimate degrees of relatedness among canids.",
          "overlapWithPaper": {
            "claimIds": [
              "C3"
            ],
            "summary": "The claims recite receiving phased haplotype data, matching IBD segments across predefined genomic bins, and aggregating weighted scores to infer pairwise relatedness. DAP's ≥10,000 low-pass WGS effort requires kinship and population-structure control for GWAS; the patented IBD segmentation and scoring procedures map directly to building relatedness matrices and detecting cryptic relationships within the cohort. This enables accurate association testing and pedigree deconvolution exactly as contemplated in the paper's genetic architecture aims."
          },
          "url": null
        },
        {
          "patentNumber": "US7729863B2",
          "title": "Methods and materials for canine breed identification",
          "assignee": "Fred Hutchinson Cancer Research Center",
          "filingDate": "2004-08-30",
          "grantDate": "2010-06-08",
          "abstract": "Panels of informative canine genetic markers and statistical classification methods to infer breed composition and relatedness of individual dogs.",
          "overlapWithPaper": {
            "claimIds": [
              "C3"
            ],
            "summary": "Independent claims cover selecting breed-informative SNPs or markers and classifying unknown dogs by comparing genotype profiles with breed reference panels. DAP's genomic analyses require robust breed assignment and stratification control to mitigate confounding in large-scale GWAS; the claimed marker selection and classifier mapping mirror the paper's approach to infer ancestry and adjust models accordingly. This enables proper population structure adjustment that is essential for the paper's planned genetic architecture studies."
          },
          "url": null
        },
        {
          "patentNumber": "GB2626276A",
          "title": "Systems and methods for a pet relative finder",
          "assignee": "Mars, Incorporated",
          "filingDate": "2022-10-26",
          "grantDate": null,
          "abstract": "Computer-implemented methods for predicting familial relationships in companion animals using DNA segment matching and IBD-based metrics.",
          "overlapWithPaper": {
            "claimIds": [
              "C3"
            ],
            "summary": "Claims 1-8 describe receiving pet genomic data, identifying local DNA fragment patterns with shared segments, and computing IBD statistics to infer kinship. DAP's nationwide cohort needs scalable relatedness detection to build relationship graphs and adjust association models; the claimed IBD matching and kinship inference steps are the same computations used to generate the cohort's relatedness matrices. This directly supports the paper's strategy to map canine genetic architecture while controlling for family structure."
          },
          "url": null
        },
        {
          "patentNumber": "US20220119864A1",
          "title": "Canid microbiome monitoring tools",
          "assignee": "Mars, Incorporated",
          "filingDate": null,
          "grantDate": null,
          "abstract": "Methods, compositions, and systems for longitudinal profiling of canid gut microbiomes, including assay panels, reference datasets, and analytics to monitor health status.",
          "overlapWithPaper": {
            "claimIds": [
              "C4"
            ],
            "summary": "The claims disclose serial faecal sampling, microbiome sequencing, and comparative analytics against a reference to detect deviations over time. DAP's Precision/TRIAD cohorts plan annual faecal collections with QA/QC and multi-omic profiling to derive biomarkers; the claimed longitudinal microbiome workflows map to the paper's biomarker development pipeline and temporal deviation detection. This enables monitoring of microbiome-based ageing and disease signatures as described in the study."
          },
          "url": null
        },
        {
          "patentNumber": "US9615547B2",
          "title": "Pet animal collar for health and vital signs monitoring, alert and diagnosis",
          "assignee": "PetPace Ltd.",
          "filingDate": null,
          "grantDate": null,
          "abstract": "A wearable collar integrating accelerometry with temperature, pulse, and respiration sensing, coupled to analytics that derive activity, posture, and health alerts.",
          "overlapWithPaper": {
            "claimIds": [
              "C4"
            ],
            "summary": "Claims cover collecting accelerometer data and physiological signals from a pet, computing activity, rest, posture, and anomaly metrics, and generating alerts. DAP specifies accelerometry and clinicopathology in its annual profiling; the claimed device and algorithms produce the continuous activity and rest features used for frailty and healthspan biomarker development. This provides instrumentation and derived measures directly aligned with the paper's multi-omic phenotyping."
          },
          "url": null
        },
        {
          "patentNumber": "WO2021124264A1",
          "title": "Veterinary formulations comprising rapamycin and methods of using the same for treating animal diseases",
          "assignee": "TriviumVet DAC",
          "filingDate": null,
          "grantDate": null,
          "abstract": "Oral veterinary dosage forms of rapamycin or rapalogs and their use to treat conditions in companion animals, including cardiac dysfunction, cancer, inflammation, and ageing effects.",
          "overlapWithPaper": {
            "claimIds": [
              "C5"
            ],
            "summary": "Independent claims recite canine-applicable oral formulations and dosing ranges for rapamycin to modulate disease processes relevant to ageing. TRIAD tests weekly low-dose rapamycin in middle-aged, large-breed dogs for lifespan and healthspan endpoints; the claimed compositions and veterinary dosing encompass the same active agent, species, and ageing-linked indications operationalised by the trial. This provides coverage over the interventional agent and practical delivery that the paper's RCT implements."
          },
          "url": null
        },
        {
          "patentNumber": "US20220401421A1",
          "title": "Veterinary formulations comprising rapamycin and methods of using the same for treating animal diseases",
          "assignee": "TriviumVet DAC",
          "filingDate": null,
          "grantDate": null,
          "abstract": "US family member describing canine-suitable rapamycin formulations and veterinary dosing methods for treating companion-animal diseases and ageing-associated conditions.",
          "overlapWithPaper": {
            "claimIds": [
              "C5"
            ],
            "summary": "Claims disclose oral dosage forms and dosing regimens for rapamycin in dogs and cats for conditions tied to ageing physiology. The TRIAD protocol's weekly low-dose rapamycin administration in dogs falls within the claimed veterinary use and dosage scope, linking the agent, species, and targeted healthspan outcomes. Thus, the patent family covers the therapeutic composition and use central to the paper's interventional study."
          },
          "url": null
        },
        {
          "patentNumber": "WO2022272120A1",
          "title": "Epigenetic clocks",
          "assignee": null,
          "filingDate": null,
          "grantDate": null,
          "abstract": "DNA methylation-based models using conserved CpG sites to estimate chronological or biological age across mammals, with embodiments for dogs and cross-species clocks and use in monitoring interventions.",
          "overlapWithPaper": {
            "claimIds": [
              "C4",
              "C5"
            ],
            "summary": "Independent disclosures specify CpG marker sets and regression frameworks for canine and dual-species epigenetic clocks and methods to quantify age shift pre- and post-treatment. DAP's annual multi-omic profiling seeks ageing biomarkers and TRIAD requires surrogate measures of biological-age response to rapamycin; the claimed methylation clocks map directly to these measurement needs. This enables objective, model-based tracking of intervention effects and normative ageing trajectories as outlined in the paper."
          },
          "url": null
        }
      ],
      "promptNotes": "No substantive patents were identified for C1 (longitudinal open cohort infrastructure), C2 (dogs as a model), C6 (open-science data/biobank policy), or C7 (ethics and participant engagement), which describe governance and operational frameworks rather than patentable technical inventions."
    }
  },
  "verifiedClaims": {
    "text": "=== OVERALL ASSESSMENT ===\nAcross claims C1-C7, the programme-level assertions are directionally supported by independent cohort profiles, methodological papers, patents, and official materials. Most claims are partially verified due to controlled rather than fully open access, incomplete milestone documentation (e.g., 10,000 genomes by 2022), and the absence of published TRIAD efficacy outcomes. Overall, the Dog Aging Project's design, open-science posture, and methodological choices are credible, with executional and completeness caveats typical of very large longitudinal cohorts.\n\n=== VERIFIED CLAIMS ===\n\nClaim: C1\nOriginal: DAP is a large, open-data, long-term longitudinal study of companion-dog ageing with nested cohorts. Evidence: Programme description with five cohorts: Pack, Foundation, Precision, TRIAD (rapamycin RCT), and Centenarian; >30,000 participants; USA-wide; lifetime follow-up.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] An open science study of ageing in companion dogs (Nature, 2022)\n    Describes the Dog Aging Project's nationwide, multi-cohort design (Pack, Foundation, Precision, TRIAD, Centenarian) and open-science framework.\n  - [Research Group] Dog Aging Project website and FAQ\n    Outlines nested cohort structure and USA-wide, long-term longitudinal follow-up with community-science enrolment.\n  - [Research Group] National Institute on Aging programme page\n    Independent description confirming a nationwide, long-term longitudinal study with tens of thousands of dogs.\n  - [Research Group] Dog Aging Project communications\n    Reports large-scale enrolment and intent for extended follow-up, supporting scale and duration claims.\n\nContradicting Evidence:\n  - [Research Group] DAP materials stating minimum 5-year follow-up\n    Some public descriptions indicate minimum five-year follow-up rather than guaranteed lifetime follow-up.\n\nSummary: Independent descriptions and the programme's own materials support that DAP is a very large, nationwide, nested-cohort, longitudinal study operating under an open-science model. However, lifetime follow-up is an intention rather than a verified completed outcome, and some official materials describe minimum five-year follow-up. Access is open via controlled agreements rather than unrestricted downloads.\n\nClaim: C2\nOriginal: Companion dogs are a suitable and socially relevant model for ageing research. Evidence: Dogs vary widely in phenotype and lifespan, share human environments and healthcare, experience human-like age-related diseases, and age ~7-10× faster, enabling feasible longitudinal and interventional studies.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] Mammalian Genome review on dogs as ageing models\n    Argues that pet dogs are translational geroscience models due to shared environments and veterinary care with humans.\n  - [Similar Paper] AJVR One Health review on ageing parallels\n    Summarises parallels in molecular and clinical ageing between humans and companion animals, supporting model suitability.\n  - [Similar Paper] JAVMA review on canine cognitive dysfunction\n    Highlights clinical and pathological similarities to human Alzheimer's disease, supporting disease analogue relevance.\n  - [Similar Paper] DAP-based social environment analyses\n    Uses companion-dog data to study social determinants of health, reinforcing social relevance and shared exposures.\n\nContradicting Evidence:\n  - [Similar Paper] 2024 review noting limited molecular longitudinal datasets in dogs\n    Acknowledges that the depth of longitudinal molecular studies in dogs is still developing compared with humans and mice.\n\nSummary: Multiple independent reviews and disease-specific evidence support dogs as socially relevant and feasible models for ageing research. The main limitation is the comparatively smaller body of longitudinal molecular datasets to date. This gap reflects a maturing field rather than fundamental unsuitability.\n\nClaim: C3\nOriginal: Primary scientific aims include defining normative canine ageing and mapping genetic architecture using ≥10,000 low-pass WGS genomes. Evidence: Aim (1) multimorbidity, frailty, inflammageing; Aim (2) ≥10,000 dogs genotyped with imputation; on track to 10,000 genomes by end of 2022.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] An open science study of ageing in companion dogs (Nature, 2022)\n    States aims to define normative ageing and collect genome-wide data with imputation for large-scale genetic analyses.\n  - [Research Group] Dog Aging Project communications on low-pass WGS\n    Describe plans and funding to sequence approximately 10,000 dogs using low-pass WGS and imputation.\n  - [Similar Paper] Ancestry-inclusive dog genomics challenges popular breed stereotypes (Science, 2022)\n    Demonstrates feasibility of community-science genetics using low-pass WGS, imputation and GWAS at large scale.\n  - [Patent] US11501851B2: Methods and systems for determining ancestral relatedness\n    IBD-based relatedness inference supports construction of kinship matrices and control of population structure in canine GWAS.\n  - [Patent] US7729863B2: Methods and materials for canine breed identification\n    Breed-informative markers and classifiers enable ancestry assignment and stratification control for large-scale genetic mapping.\n\nContradicting Evidence:\n  - [Research Group] No independent public confirmation of 10,000 genomes by end of 2022\n    The specific milestone of reaching 10,000 genomes by 2022 lacks verifiable public documentation.\n\nSummary: The programme's aims and methodological plan for low-pass WGS with imputation are consistent with published strategies and proven feasible by independent large-scale canine genomics work. However, the specific milestone of achieving 10,000 genomes by the end of 2022 is not independently confirmed. Genetic architecture mapping remains contingent on dataset completion and public documentation.\n\nClaim: C4\nOriginal: Annual multi-omic profiling in Precision and TRIAD will support biomarker development. Evidence: Biospecimen kits with blood, plasma/serum, urine, hair, faeces; clinicopathology; accelerometry; processing pipelines and QA/QC described.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Similar Paper] Precision cohort multi-omics design (GeroScience, 2025)\n    Details repeated annual biospecimen collection, clinicopathology and multi-omic assays with QA/QC pipelines in the Precision cohort.\n  - [Similar Paper] DNA methylation clocks for dogs and humans (PNAS, 2022)\n    Provides validated epigenetic biomarkers and time-to-death estimators that align with DAP's biomarker development aims.\n  - [Similar Paper] Cohort profile: Golden Retriever Lifetime Study (PLOS ONE, 2022)\n    Demonstrates feasibility of annual veterinary exams and biospecimen banking in a large canine cohort.\n  - [Patent] US9615547B2: Pet animal collar for health and vital signs monitoring\n    Accelerometry-derived activity and rest metrics map to frailty and healthspan features planned for biomarker work.\n  - [Patent] US20220119864A1: Canid microbiome monitoring tools\n    Longitudinal faecal sampling and analytics support microbiome biomarkers consistent with the planned profiling.\n\nContradicting Evidence:\n  - [Similar Paper] Precision cohort methods note missing-sample challenges\n    Operational gaps in complete biospecimen capture may limit longitudinal multi-omic completeness.\n\nSummary: Precision's annual multi-omics and QA/QC are documented and align with established biomarker methods in genomics, wearables and microbiome analyses. TRIAD intends similar profiling to enable biomarker development, though public operational detail is sparser. Sample completeness and cross-platform harmonisation are practical risks.\n\nClaim: C5\nOriginal: The TRIAD trial will test whether one year of weekly low-dose rapamycin improves lifespan and healthspan in large-breed, middle-aged dogs. Evidence: Randomised, double-masked, placebo-controlled design; endpoints include lifespan, heart and cognitive function, and age-related disease incidence; enrolment began 06/2021.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Research Group] Dog Aging Project TRIAD information pages and blog\n    Describe randomised, double-masked, placebo-controlled weekly dosing for one year and healthspan endpoints with extended follow-up.\n  - [Research Group] Washington State University trial listing\n    Independent registry entry confirming design, weekly dosing duration and survival and health outcomes.\n  - [Similar Paper] A randomized controlled trial of short-term rapamycin in companion dogs (GeroScience, 2017)\n    Provides feasibility and safety template with echocardiography endpoints that TRIAD builds upon.\n  - [Research Group] NIH RePORTER grant record\n    States aims to test effects on lifespan and disease incidence in a large, multicentre cohort of dogs.\n  - [Patent] WO2021124264A1: Veterinary formulations comprising rapamycin\n    Describes canine-appropriate oral formulations and dosing ranges relevant to TRIAD's intervention.\n\nContradicting Evidence:\n  - [Research Group] Trial listing shows enrolment start on 15 July 2021\n    Contradicts the stated June 2021 start month by approximately one month.\n  - [Research Group] No peer-reviewed efficacy results published yet\n    Efficacy on lifespan and healthspan remains unproven pending publication.\n\nSummary: The trial's randomised, double-masked, placebo-controlled design with one-year weekly rapamycin dosing and healthspan endpoints is well documented across programme and registry sources, supported by prior canine rapamycin RCT feasibility. The specific start month is slightly off, and no efficacy results are yet published. Consequently, the claim about testing is accurate, but outcomes remain to be shown.\n\nClaim: C6\nOriginal: DAP commits to open science through public data releases and a Biobank. Evidence: De-identified data available on Terra via data use agreement; subset of biospecimens banked at Cornell and available to qualified researchers with data return requirement.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Research Group] DAP Terra data access hub and curated releases\n    Shows recurring de-identified data releases with documentation and user guides under an open-science model.\n  - [Similar Paper] Precision cohort paper reiterating open-data access\n    Confirms that data are made available via Terra and describes the open-science approach.\n  - [Research Group] Cornell Veterinary Biobank partnership\n    Confirms accredited biobank storage and availability of biospecimens to qualified researchers with data return obligations.\n\nContradicting Evidence:\n  - [Research Group] Data access via DUA rather than unrestricted download\n    Indicates controlled-access open science instead of fully open public release.\n\nSummary: There is clear evidence of ongoing public releases through Terra and of a formal biobanking partnership enabling external access to specimens. Access is mediated by a data use agreement and not by unrestricted downloads, which is typical for health-linked datasets. The commitment to open science is therefore supported but controlled.\n\nClaim: C7\nOriginal: Robust ethics, governance, and participant engagement underpin study feasibility and retention. Evidence: IACUC approvals; informed consent; advisory boards; strong owner engagement via newsletter, helpdesk, and private community.\nStatus: Partially Verified\nConfidence: Moderate\n\nSupporting Evidence:\n  - [Research Group] DAP oversight pages (IRB/IACUC approvals)\n    Document human-subjects determinations and animal-use approvals across participating institutions, including TRIAD.\n  - [Research Group] DAP consent materials and help centre\n    Provide participant-facing consent explanations and ongoing support channels.\n  - [Research Group] DAP newsletters and community updates\n    Indicate sustained participant engagement and communications infrastructure.\n\nContradicting Evidence:\n  - [Similar Paper] Precision cohort methods noting missing-sample issues\n    Suggests practical retention and compliance challenges in a large, decentralised cohort.\n\nSummary: Ethics approvals and governance structures are publicly documented, and participant engagement mechanisms are active. Nonetheless, operational issues such as missing samples indicate that retention and compliance challenges remain. These do not negate governance robustness but highlight ongoing feasibility risks.\n",
    "structured": {
      "claims": [
        {
          "claimId": "C1",
          "originalClaim": "DAP is a large, open-data, long-term longitudinal study of companion-dog ageing with nested cohorts. Evidence: Programme description with five cohorts: Pack, Foundation, Precision, TRIAD (rapamycin RCT), and Centenarian; >30,000 participants; USA-wide; lifetime follow-up.",
          "verificationStatus": "Partially Verified",
          "supportingEvidence": [
            {
              "source": "Similar Paper",
              "title": "An open science study of ageing in companion dogs (Nature, 2022)",
              "relevance": "Describes the Dog Aging Project's nationwide, multi-cohort design (Pack, Foundation, Precision, TRIAD, Centenarian) and open-science framework."
            },
            {
              "source": "Research Group",
              "title": "Dog Aging Project website and FAQ",
              "relevance": "Outlines nested cohort structure and USA-wide, long-term longitudinal follow-up with community-science enrolment."
            },
            {
              "source": "Research Group",
              "title": "National Institute on Aging programme page",
              "relevance": "Independent description confirming a nationwide, long-term longitudinal study with tens of thousands of dogs."
            },
            {
              "source": "Research Group",
              "title": "Dog Aging Project communications",
              "relevance": "Reports large-scale enrolment and intent for extended follow-up, supporting scale and duration claims."
            }
          ],
          "contradictingEvidence": [
            {
              "source": "Research Group",
              "title": "DAP materials stating minimum 5-year follow-up",
              "relevance": "Some public descriptions indicate minimum five-year follow-up rather than guaranteed lifetime follow-up."
            }
          ],
          "verificationSummary": "Independent descriptions and the programme's own materials support that DAP is a very large, nationwide, nested-cohort, longitudinal study operating under an open-science model. However, lifetime follow-up is an intention rather than a verified completed outcome, and some official materials describe minimum five-year follow-up. Access is open via controlled agreements rather than unrestricted downloads.",
          "confidenceLevel": "Moderate"
        },
        {
          "claimId": "C2",
          "originalClaim": "Companion dogs are a suitable and socially relevant model for ageing research. Evidence: Dogs vary widely in phenotype and lifespan, share human environments and healthcare, experience human-like age-related diseases, and age ~7-10× faster, enabling feasible longitudinal and interventional studies.",
          "verificationStatus": "Partially Verified",
          "supportingEvidence": [
            {
              "source": "Similar Paper",
              "title": "Mammalian Genome review on dogs as ageing models",
              "relevance": "Argues that pet dogs are translational geroscience models due to shared environments and veterinary care with humans."
            },
            {
              "source": "Similar Paper",
              "title": "AJVR One Health review on ageing parallels",
              "relevance": "Summarises parallels in molecular and clinical ageing between humans and companion animals, supporting model suitability."
            },
            {
              "source": "Similar Paper",
              "title": "JAVMA review on canine cognitive dysfunction",
              "relevance": "Highlights clinical and pathological similarities to human Alzheimer's disease, supporting disease analogue relevance."
            },
            {
              "source": "Similar Paper",
              "title": "DAP-based social environment analyses",
              "relevance": "Uses companion-dog data to study social determinants of health, reinforcing social relevance and shared exposures."
            }
          ],
          "contradictingEvidence": [
            {
              "source": "Similar Paper",
              "title": "2024 review noting limited molecular longitudinal datasets in dogs",
              "relevance": "Acknowledges that the depth of longitudinal molecular studies in dogs is still developing compared with humans and mice."
            }
          ],
          "verificationSummary": "Multiple independent reviews and disease-specific evidence support dogs as socially relevant and feasible models for ageing research. The main limitation is the comparatively smaller body of longitudinal molecular datasets to date. This gap reflects a maturing field rather than fundamental unsuitability.",
          "confidenceLevel": "Moderate"
        },
        {
          "claimId": "C3",
          "originalClaim": "Primary scientific aims include defining normative canine ageing and mapping genetic architecture using ≥10,000 low-pass WGS genomes. Evidence: Aim (1) multimorbidity, frailty, inflammageing; Aim (2) ≥10,000 dogs genotyped with imputation; on track to 10,000 genomes by end of 2022.",
          "verificationStatus": "Partially Verified",
          "supportingEvidence": [
            {
              "source": "Similar Paper",
              "title": "An open science study of ageing in companion dogs (Nature, 2022)",
              "relevance": "States aims to define normative ageing and collect genome-wide data with imputation for large-scale genetic analyses."
            },
            {
              "source": "Research Group",
              "title": "Dog Aging Project communications on low-pass WGS",
              "relevance": "Describe plans and funding to sequence approximately 10,000 dogs using low-pass WGS and imputation."
            },
            {
              "source": "Similar Paper",
              "title": "Ancestry-inclusive dog genomics challenges popular breed stereotypes (Science, 2022)",
              "relevance": "Demonstrates feasibility of community-science genetics using low-pass WGS, imputation and GWAS at large scale."
            },
            {
              "source": "Patent",
              "title": "US11501851B2: Methods and systems for determining ancestral relatedness",
              "relevance": "IBD-based relatedness inference supports construction of kinship matrices and control of population structure in canine GWAS."
            },
            {
              "source": "Patent",
              "title": "US7729863B2: Methods and materials for canine breed identification",
              "relevance": "Breed-informative markers and classifiers enable ancestry assignment and stratification control for large-scale genetic mapping."
            }
          ],
          "contradictingEvidence": [
            {
              "source": "Research Group",
              "title": "No independent public confirmation of 10,000 genomes by end of 2022",
              "relevance": "The specific milestone of reaching 10,000 genomes by 2022 lacks verifiable public documentation."
            }
          ],
          "verificationSummary": "The programme's aims and methodological plan for low-pass WGS with imputation are consistent with published strategies and proven feasible by independent large-scale canine genomics work. However, the specific milestone of achieving 10,000 genomes by the end of 2022 is not independently confirmed. Genetic architecture mapping remains contingent on dataset completion and public documentation.",
          "confidenceLevel": "Moderate"
        },
        {
          "claimId": "C4",
          "originalClaim": "Annual multi-omic profiling in Precision and TRIAD will support biomarker development. Evidence: Biospecimen kits with blood, plasma/serum, urine, hair, faeces; clinicopathology; accelerometry; processing pipelines and QA/QC described.",
          "verificationStatus": "Partially Verified",
          "supportingEvidence": [
            {
              "source": "Similar Paper",
              "title": "Precision cohort multi-omics design (GeroScience, 2025)",
              "relevance": "Details repeated annual biospecimen collection, clinicopathology and multi-omic assays with QA/QC pipelines in the Precision cohort."
            },
            {
              "source": "Similar Paper",
              "title": "DNA methylation clocks for dogs and humans (PNAS, 2022)",
              "relevance": "Provides validated epigenetic biomarkers and time-to-death estimators that align with DAP's biomarker development aims."
            },
            {
              "source": "Similar Paper",
              "title": "Cohort profile: Golden Retriever Lifetime Study (PLOS ONE, 2022)",
              "relevance": "Demonstrates feasibility of annual veterinary exams and biospecimen banking in a large canine cohort."
            },
            {
              "source": "Patent",
              "title": "US9615547B2: Pet animal collar for health and vital signs monitoring",
              "relevance": "Accelerometry-derived activity and rest metrics map to frailty and healthspan features planned for biomarker work."
            },
            {
              "source": "Patent",
              "title": "US20220119864A1: Canid microbiome monitoring tools",
              "relevance": "Longitudinal faecal sampling and analytics support microbiome biomarkers consistent with the planned profiling."
            }
          ],
          "contradictingEvidence": [
            {
              "source": "Similar Paper",
              "title": "Precision cohort methods note missing-sample challenges",
              "relevance": "Operational gaps in complete biospecimen capture may limit longitudinal multi-omic completeness."
            }
          ],
          "verificationSummary": "Precision's annual multi-omics and QA/QC are documented and align with established biomarker methods in genomics, wearables and microbiome analyses. TRIAD intends similar profiling to enable biomarker development, though public operational detail is sparser. Sample completeness and cross-platform harmonisation are practical risks.",
          "confidenceLevel": "Moderate"
        },
        {
          "claimId": "C5",
          "originalClaim": "The TRIAD trial will test whether one year of weekly low-dose rapamycin improves lifespan and healthspan in large-breed, middle-aged dogs. Evidence: Randomised, double-masked, placebo-controlled design; endpoints include lifespan, heart and cognitive function, and age-related disease incidence; enrolment began 06/2021.",
          "verificationStatus": "Partially Verified",
          "supportingEvidence": [
            {
              "source": "Research Group",
              "title": "Dog Aging Project TRIAD information pages and blog",
              "relevance": "Describe randomised, double-masked, placebo-controlled weekly dosing for one year and healthspan endpoints with extended follow-up."
            },
            {
              "source": "Research Group",
              "title": "Washington State University trial listing",
              "relevance": "Independent registry entry confirming design, weekly dosing duration and survival and health outcomes."
            },
            {
              "source": "Similar Paper",
              "title": "A randomized controlled trial of short-term rapamycin in companion dogs (GeroScience, 2017)",
              "relevance": "Provides feasibility and safety template with echocardiography endpoints that TRIAD builds upon."
            },
            {
              "source": "Research Group",
              "title": "NIH RePORTER grant record",
              "relevance": "States aims to test effects on lifespan and disease incidence in a large, multicentre cohort of dogs."
            },
            {
              "source": "Patent",
              "title": "WO2021124264A1: Veterinary formulations comprising rapamycin",
              "relevance": "Describes canine-appropriate oral formulations and dosing ranges relevant to TRIAD's intervention."
            }
          ],
          "contradictingEvidence": [
            {
              "source": "Research Group",
              "title": "Trial listing shows enrolment start on 15 July 2021",
              "relevance": "Contradicts the stated June 2021 start month by approximately one month."
            },
            {
              "source": "Research Group",
              "title": "No peer-reviewed efficacy results published yet",
              "relevance": "Efficacy on lifespan and healthspan remains unproven pending publication."
            }
          ],
          "verificationSummary": "The trial's randomised, double-masked, placebo-controlled design with one-year weekly rapamycin dosing and healthspan endpoints is well documented across programme and registry sources, supported by prior canine rapamycin RCT feasibility. The specific start month is slightly off, and no efficacy results are yet published. Consequently, the claim about testing is accurate, but outcomes remain to be shown.",
          "confidenceLevel": "Moderate"
        },
        {
          "claimId": "C6",
          "originalClaim": "DAP commits to open science through public data releases and a Biobank. Evidence: De-identified data available on Terra via data use agreement; subset of biospecimens banked at Cornell and available to qualified researchers with data return requirement.",
          "verificationStatus": "Partially Verified",
          "supportingEvidence": [
            {
              "source": "Research Group",
              "title": "DAP Terra data access hub and curated releases",
              "relevance": "Shows recurring de-identified data releases with documentation and user guides under an open-science model."
            },
            {
              "source": "Similar Paper",
              "title": "Precision cohort paper reiterating open-data access",
              "relevance": "Confirms that data are made available via Terra and describes the open-science approach."
            },
            {
              "source": "Research Group",
              "title": "Cornell Veterinary Biobank partnership",
              "relevance": "Confirms accredited biobank storage and availability of biospecimens to qualified researchers with data return obligations."
            }
          ],
          "contradictingEvidence": [
            {
              "source": "Research Group",
              "title": "Data access via DUA rather than unrestricted download",
              "relevance": "Indicates controlled-access open science instead of fully open public release."
            }
          ],
          "verificationSummary": "There is clear evidence of ongoing public releases through Terra and of a formal biobanking partnership enabling external access to specimens. Access is mediated by a data use agreement and not by unrestricted downloads, which is typical for health-linked datasets. The commitment to open science is therefore supported but controlled.",
          "confidenceLevel": "Moderate"
        },
        {
          "claimId": "C7",
          "originalClaim": "Robust ethics, governance, and participant engagement underpin study feasibility and retention. Evidence: IACUC approvals; informed consent; advisory boards; strong owner engagement via newsletter, helpdesk, and private community.",
          "verificationStatus": "Partially Verified",
          "supportingEvidence": [
            {
              "source": "Research Group",
              "title": "DAP oversight pages (IRB/IACUC approvals)",
              "relevance": "Document human-subjects determinations and animal-use approvals across participating institutions, including TRIAD."
            },
            {
              "source": "Research Group",
              "title": "DAP consent materials and help centre",
              "relevance": "Provide participant-facing consent explanations and ongoing support channels."
            },
            {
              "source": "Research Group",
              "title": "DAP newsletters and community updates",
              "relevance": "Indicate sustained participant engagement and communications infrastructure."
            }
          ],
          "contradictingEvidence": [
            {
              "source": "Similar Paper",
              "title": "Precision cohort methods noting missing-sample issues",
              "relevance": "Suggests practical retention and compliance challenges in a large, decentralised cohort."
            }
          ],
          "verificationSummary": "Ethics approvals and governance structures are publicly documented, and participant engagement mechanisms are active. Nonetheless, operational issues such as missing samples indicate that retention and compliance challenges remain. These do not negate governance robustness but highlight ongoing feasibility risks.",
          "confidenceLevel": "Moderate"
        }
      ],
      "overallAssessment": "Across claims C1-C7, the programme-level assertions are directionally supported by independent cohort profiles, methodological papers, patents, and official materials. Most claims are partially verified due to controlled rather than fully open access, incomplete milestone documentation (e.g., 10,000 genomes by 2022), and the absence of published TRIAD efficacy outcomes. Overall, the Dog Aging Project's design, open-science posture, and methodological choices are credible, with executional and completeness caveats typical of very large longitudinal cohorts.",
      "promptNotes": ""
    }
  }
} as const;
